hg_34520.1

Basic information about the TSS

---

TSS ID: hg_34520.1 Species: human Chr: chr2		Start: 231461986 End: 231461997 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK001314 Distance: 303 GeneID: 4691 HGNC/MGI_ID: HGNC:7667 UniProt_ID:

Gene_name: nucleolin Gene_symbol: NCL Gene_synonyms: C23 Nsr1 Gene_source: HGNC:7667

TATA-Box annotation

---

Distance to TSS:	-1550
Nearest PromoterID:	NR_004398
Entrez ID:	25826
Nearest Unigene:
Nearest Refseq:	NR_004398
Nearest Ensembl:	ENSG00000202400
Gene Name:	nucleolin
Gene Alias:	RNU82|U82|Z25
Gene Description:	small nucleolar RNA, C/D box 82
Gene Type:	snoRNA
CpG%:	0.01
GC%:	0.477612
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NCL p2@NCL p4@NCL p5@NCL p6@NCL p7@NCL p8@NCL p9@NCL p10@NCL
Sample		p1@NCL	p2@NCL	p4@NCL	p5@NCL	p6@NCL	p7@NCL	p8@NCL	p9@NCL	p10@NCL
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	760.90	21.62	7.40	13.64	4.09	1.36	4.87	4.68	2.53
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	714.99	24.68	8.50	9.51	6.68	1.42	2.83	3.03	2.83
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	790.52	28.55	8.29	15.05	5.02	0.77	3.86	3.67	2.70
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	681.53	15.59	3.74	11.02	2.70	1.87	2.70	2.91	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	739.01	21.37	8.55	12.82	4.50	1.12	2.25	2.92	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	822.92	21.71	5.43	14.15	4.65	1.16	2.13	4.26	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	897.68	40.74	10.02	13.07	5.66	1.53	4.79	3.27	5.66
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	842.20	23.74	7.99	11.38	3.15	1.70	2.91	1.94	3.39
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	666.16	14.75	5.34	7.91	4.49	1.71	1.92	2.35	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	664.25	11.01	3.48	8.11	2.90	1.16	1.74	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	578.05	10.51	5.66	6.47	0.81	2.02	1.62	2.43	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	622.84	9.35	4.07	5.69	1.63	2.85	2.44	3.25	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	201.97	5.80	2.10	3.06	1.45	2.74	1.13	0.32	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	210.04	7.37	3.16	2.71	0.75	3.01	1.20	0.45	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	189.04	6.15	2.20	3.07	1.10	3.29	1.32	0.00	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	208.23	3.27	2.01	2.01	0.75	2.01	2.77	0.50	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	216.44	6.77	2.62	2.62	0.87	2.40	0.87	0.44	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	201.21	6.75	0.84	5.48	2.53	2.53	0.84	0.84	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	220.19	4.27	1.07	3.20	0.00	4.80	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	201.14	4.66	2.26	2.56	1.05	2.86	1.50	0.45	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	201.68	6.95	3.47	3.34	1.34	2.27	0.80	0.67	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	217.33	5.87	3.45	3.97	1.04	3.11	1.21	1.21	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	239.38	6.85	3.23	2.71	0.90	2.33	0.65	0.26	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	219.86	4.61	3.15	2.91	1.21	1.46	1.21	0.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	226.00	6.45	3.87	2.84	1.29	3.10	0.77	0.26	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	192.76	4.75	3.80	4.43	0.63	2.22	1.58	0.32	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	240.11	4.40	5.49	4.95	0.00	2.75	0.55	0.55	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	254.61	13.91	4.48	7.07	1.89	3.30	3.54	0.24	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	175.25	5.01	3.39	4.04	1.45	1.78	1.13	0.16	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	232.00	6.70	3.62	3.26	1.09	2.53	0.72	0.36	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	195.32	1.67	3.35	1.47	1.05	1.67	0.42	0.21	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	196.16	3.52	2.74	2.15	0.20	1.76	0.98	0.20	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	191.83	6.75	3.80	3.38	1.27	3.80	1.06	0.42	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	319.98	11.22	3.79	4.12	1.48	3.30	1.32	0.82	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	242.71	5.42	4.67	3.18	0.93	2.24	2.06	0.56	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	202.16	3.45	3.45	1.34	1.34	2.30	2.11	1.15	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	208.47	7.77	3.68	3.07	2.04	2.04	1.43	0.82	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	205.32	4.23	4.23	2.82	0.40	2.01	1.61	0.40	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	228.24	8.10	4.59	5.13	1.35	3.51	1.62	1.08	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	213.66	6.72	3.60	5.28	1.20	2.16	0.96	1.44	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	200.21	4.23	3.29	1.88	0.71	2.35	0.94	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	261.75	7.17	3.95	2.64	0.44	3.22	0.44	0.29	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	254.55	4.85	2.53	1.27	1.48	1.27	1.05	0.63	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	193.53	5.07	4.72	2.27	1.40	2.62	1.22	0.70	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	206.80	6.42	3.21	3.21	1.61	2.41	2.41	0.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	191.70	10.47	3.95	5.12	2.33	3.26	1.86	0.93	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	210.16	3.12	5.04	1.68	0.96	1.92	0.72	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	161.54	3.87	2.68	1.79	0.60	0.89	1.49	0.30	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	183.84	1.20	3.11	1.20	0.00	1.91	1.44	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	185.01	2.22	1.62	2.22	0.81	1.82	2.83	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	180.15	5.12	3.48	2.87	1.23	1.23	1.23	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	182.35	3.56	1.78	2.89	1.11	2.22	0.44	0.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	6422.41	1343.25	237.87	419.77	265.85	153.91	97.95	153.91	335.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	201.56	3.90	5.68	2.13	1.42	2.13	1.06	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	182.59	2.98	2.32	1.33	0.66	1.33	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	843.97	48.66	29.36	31.88	14.26	9.23	10.91	6.71	8.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	248.91	5.97	5.05	4.59	3.67	4.13	1.84	1.84	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	201.60	1.30	3.57	0.97	0.65	1.94	0.97	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	167.97	0.64	2.57	0.00	0.00	1.93	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	217.83	5.97	6.92	3.46	1.26	4.09	1.26	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	179.08	3.53	2.12	0.00	0.71	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	176.09	0.56	1.12	1.12	0.56	2.24	0.56	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	246.01	5.57	5.57	13.53	2.39	5.57	3.18	0.00	7.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	139.30	3.74	3.74	2.72	0.34	2.38	1.02	0.68	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	168.96	0.97	3.90	0.97	0.32	1.95	0.32	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	124.95	1.77	1.42	1.06	0.00	1.42	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	4800.69	905.18	113.15	307.11	129.31	177.80	48.49	64.66	177.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	3648.64	497.54	110.56	142.15	118.46	78.97	15.79	0.00	55.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	150.15	3.41	1.46	0.98	0.49	0.00	1.46	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	149.26	1.98	4.96	0.50	0.99	2.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	134.64	0.47	0.94	0.47	0.47	1.88	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	160.96	3.64	2.98	1.32	0.99	1.99	0.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	151.58	1.86	2.17	0.93	0.62	1.24	0.00	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	163.88	0.92	3.67	1.22	0.00	0.31	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	240.11	5.07	5.07	1.58	0.63	2.53	0.32	0.63	1.74
Adipocyte - breast, donor2	11327-117E4	222.83	20.70	4.33	7.22	4.01	1.60	1.44	1.12	1.93
Adipocyte - omental, donor1	11473-119C6	321.38	5.98	5.22	3.56	0.89	2.29	0.38	0.25	1.65
Adipocyte - omental, donor2	11474-119C7	122.59	0.75	5.23	2.24	1.49	0.00	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	144.35	1.00	2.01	2.01	2.01	0.33	0.67	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	151.20	1.91	1.91	1.91	0.64	1.91	0.64	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	126.44	1.10	1.10	0.00	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	405.11	11.74	5.87	4.97	1.81	2.71	1.35	2.26	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	204.53	12.51	4.52	2.95	2.61	0.35	1.74	1.56	1.91
Adipocyte differentiation, day04, donor1	13019-139D4	434.56	6.65	8.41	1.17	1.37	4.69	1.17	0.78	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	262.27	7.21	2.06	1.29	2.06	3.09	0.26	1.54	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	258.70	4.18	5.30	0.84	1.12	1.95	1.12	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	294.49	5.88	7.64	0.59	1.76	2.94	1.76	0.59	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	556.68	10.30	11.18	3.46	2.33	3.14	1.05	0.72	1.53
Adipocyte differentiation, day08, donor2	13023-139D8	243.68	7.10	8.71	1.29	1.29	2.58	0.65	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	222.87	10.13	4.27	1.07	3.73	1.07	0.53	1.60	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	255.96	3.34	6.12	6.12	0.00	1.67	0.00	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	127.68	2.08	5.82	1.66	0.00	1.66	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	169.03	3.52	4.02	1.51	1.26	1.76	1.00	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	165.26	4.25	5.24	0.65	0.33	1.31	0.33	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	213.13	3.04	7.61	1.52	1.83	0.61	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	172.16	2.87	1.10	0.22	1.10	0.66	0.00	0.66	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	79.61	1.43	0.36	0.72	0.72	0.00	0.72	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	154.18	2.52	1.44	2.34	0.18	0.18	0.36	0.36	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	58.57	1.67	1.67	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	81.77	2.47	1.44	1.23	0.62	0.41	0.21	0.41	0.41
Anulus Pulposus Cell, donor1	11248-116E6	325.31	9.38	7.32	2.86	1.26	4.69	1.14	1.14	0.69
Anulus Pulposus Cell, donor2	11463-119B5	127.84	1.47	3.43	1.47	1.47	2.20	1.22	0.49	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	174.33	8.09	7.64	4.04	4.04	2.70	1.35	1.80	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	217.07	16.93	3.04	6.95	5.64	2.60	3.04	3.47	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	211.88	32.10	4.28	12.84	4.28	2.14	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	185.93	13.45	3.59	3.89	4.18	3.89	3.29	2.39	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	216.26	17.71	11.38	7.59	2.53	2.53	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	176.90	15.84	3.96	3.96	1.32	3.30	1.98	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	157.89	10.72	4.55	3.25	0.97	2.27	1.30	0.97	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	172.33	11.17	4.37	2.91	5.34	3.40	2.43	1.46	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	204.89	11.88	4.16	5.34	3.56	1.19	0.00	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	199.99	13.94	4.14	3.01	3.39	3.01	2.64	1.51	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	173.44	13.79	2.18	5.81	4.35	5.81	0.73	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	99.05	13.79	2.51	6.27	2.51	1.25	3.76	0.00	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	269.01	4.61	3.29	0.16	0.16	3.95	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	156.95	8.19	6.82	2.73	4.09	5.46	0.00	4.09	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	154.41	1.36	2.71	0.30	0.30	1.96	0.30	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	175.74	9.11	4.29	2.14	2.14	4.82	0.00	2.14	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	185.53	8.12	4.16	3.40	2.83	2.27	0.57	1.89	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	233.88	22.18	5.35	4.81	3.47	4.28	1.87	4.28	2.67
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	151.20	6.83	2.93	3.90	2.93	1.95	0.98	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	196.88	9.79	4.98	3.15	2.32	2.32	1.66	1.49	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	171.70	10.81	3.60	1.20	0.00	1.20	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	123.91	0.00	3.54	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	204.64	14.75	4.29	4.63	2.92	5.49	2.40	1.89	1.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	125.85	8.39	4.19	4.19	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	178.64	6.31	2.91	4.37	3.88	2.43	2.91	0.49	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	247.78	15.18	6.07	1.90	3.42	5.31	2.28	2.66	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	199.88	21.80	7.27	2.42	0.00	1.21	1.21	0.00	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	165.31	5.13	5.70	0.57	3.42	5.70	0.00	0.57	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	167.17	8.34	4.49	5.99	2.57	4.06	0.86	1.28	2.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	153.82	9.81	2.58	2.58	1.29	3.10	1.03	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	146.86	5.16	6.10	0.94	3.75	2.35	1.88	1.41	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	193.57	16.72	3.86	7.72	2.89	3.86	3.22	3.54	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	154.11	9.27	2.14	3.57	0.00	3.57	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	142.73	14.04	3.51	7.60	1.75	2.92	0.58	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	222.19	14.45	3.61	3.01	3.31	5.42	1.20	1.81	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	167.51	4.75	1.19	1.19	1.19	1.19	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	198.34	10.17	6.61	2.03	2.54	6.10	1.02	3.56	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	235.33	16.81	3.31	6.62	4.08	4.08	2.80	2.55	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	122.63	6.35	1.27	1.27	1.27	2.54	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	163.55	11.65	4.75	1.29	1.73	5.18	1.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	189.04	10.16	4.02	1.91	2.12	5.29	0.85	1.69	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	146.15	12.18	3.19	2.03	1.74	0.87	0.58	1.45	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	169.11	18.89	8.50	5.67	0.94	4.72	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	185.80	8.65	3.39	2.54	2.37	3.90	1.19	0.85	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	171.41	11.58	0.00	4.63	6.95	2.32	0.00	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	190.13	16.90	4.23	0.00	8.45	4.23	0.00	0.00	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	196.83	4.72	3.65	3.65	3.86	4.29	0.64	0.86	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	207.57	9.63	4.21	1.80	1.20	0.60	0.00	1.20	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	153.09	5.83	4.37	5.83	2.19	2.19	0.73	0.73	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	227.81	10.57	3.45	3.45	3.91	4.37	1.38	1.15	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	293.28	58.66	2.55	7.65	10.20	10.20	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	188.89	2.80	4.07	0.25	0.00	1.53	0.76	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	217.79	12.59	5.16	4.34	3.72	3.92	1.24	2.27	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	186.35	13.77	2.75	3.67	1.53	2.45	1.22	1.84	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	204.59	11.47	7.65	3.35	2.87	5.74	1.91	2.39	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	179.17	14.63	5.32	6.21	3.33	2.66	1.11	0.67	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	152.58	16.78	3.05	4.58	1.53	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	147.89	5.54	3.32	0.00	1.11	3.32	1.66	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	185.09	9.27	3.71	5.30	3.44	2.91	2.38	1.59	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	169.37	13.81	4.00	2.54	1.45	2.54	1.09	0.36	2.18
Astrocyte - cerebellum, donor1	11500-119F6	182.14	0.61	3.07	1.11	0.37	2.70	0.25	0.49	0.25
Astrocyte - cerebellum, donor2	11580-120F5	74.45	0.51	1.03	1.03	0.68	0.68	0.51	0.68	0.00
Astrocyte - cerebellum, donor3	11661-122F5	59.36	2.10	0.42	0.00	0.63	1.68	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	516.95	11.15	10.46	3.14	1.74	5.23	1.05	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	535.47	47.08	7.12	9.71	10.19	3.56	3.07	2.91	3.56
Astrocyte - cerebral cortex, donor3	11392-118C6	455.68	26.40	6.41	5.37	3.73	2.24	1.94	1.64	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1663.05	148.06	26.61	24.31	19.50	12.27	13.30	18.69	11.35
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1973.44	153.97	25.93	25.56	23.18	16.79	12.78	13.53	11.90
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1926.69	153.63	29.36	25.60	19.12	12.86	11.83	19.12	11.38
Basophils, donor1	12241-129G9	195.89	1.57	8.89	1.05	0.52	0.00	0.52	0.26	0.26
Basophils, donor2	12242-129H1	588.46	6.86	24.17	1.08	1.08	0.36	0.72	0.36	0.72
Basophils, donor3	12243-129H2	285.32	4.12	16.46	2.20	1.03	0.29	0.29	0.29	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	100.04	1.72	0.43	0.65	0.43	0.65	0.00	0.22	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	25.15	0.91	0.00	0.46	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	408.89	7.17	7.17	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	278.68	1.88	1.26	0.00	0.00	1.26	0.63	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	144.73	1.25	1.66	1.04	0.42	0.83	0.21	0.83	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	105.47	0.69	2.07	0.23	0.69	0.00	0.46	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	340.10	40.85	5.76	10.62	8.64	1.80	5.76	2.88	4.86
Burkitt's lymphoma cell line:DAUDI	10422-106C8	1494.30	53.69	5.56	17.42	6.49	10.20	5.26	4.12	7.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	1602.61	72.90	10.95	20.26	8.62	8.85	7.45	4.66	7.92
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	799.44	4.16	8.95	1.92	0.96	7.67	0.96	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	837.70	0.00	20.68	0.00	0.00	10.34	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	273.32	6.76	14.65	0.00	0.56	1.13	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	261.51	32.11	14.85	9.84	9.65	0.00	3.16	5.57	3.90
CD14+ Monocytes, donor3	11381-118B4	205.27	20.64	12.51	5.27	5.27	0.22	2.63	1.10	1.98
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	267.19	4.81	7.64	1.42	0.28	0.00	0.28	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	319.18	2.65	6.44	1.52	0.76	0.00	0.76	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	356.35	7.23	8.22	0.99	0.66	0.00	0.33	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	189.50	20.09	9.25	5.78	2.31	0.00	2.17	1.45	3.04
CD14+ monocytes - mock treated, donor2	11873-125C1	198.25	13.88	8.75	6.34	2.11	0.30	0.30	1.21	3.32
CD14+ monocytes - mock treated, donor3	11883-125D2	223.63	9.24	10.90	3.08	2.61	0.00	2.37	1.18	2.84
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	175.27	14.06	7.20	4.85	1.17	0.00	1.34	0.67	2.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	208.11	13.25	6.62	6.07	2.48	0.00	2.21	1.10	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	290.57	15.12	8.18	6.45	4.71	0.00	1.98	0.99	4.46
CD14+ monocytes - treated with BCG, donor1	11860-125A6	156.44	10.38	4.90	4.11	1.37	0.00	1.57	0.78	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	166.12	10.33	8.19	3.92	1.60	0.00	1.25	0.71	2.49
CD14+ monocytes - treated with BCG, donor3	11880-125C8	269.86	6.31	6.96	3.05	1.31	0.22	0.65	0.65	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	194.79	11.00	7.73	4.45	2.58	0.00	0.70	0.94	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	343.22	13.73	10.03	9.50	5.28	1.06	3.70	1.58	5.81
CD14+ monocytes - treated with Candida, donor3	11888-125D7	289.54	5.55	12.20	9.98	3.33	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	187.72	16.21	7.14	5.50	3.12	0.15	1.64	1.93	3.12
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	233.07	14.57	8.18	7.38	3.19	0.60	1.80	1.00	3.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	288.36	5.83	10.62	3.96	1.04	0.00	0.62	0.83	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	177.31	17.16	8.92	4.12	4.35	0.23	1.37	1.60	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	315.10	3.85	9.50	3.39	1.58	0.23	0.45	0.23	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	221.29	12.22	5.67	4.36	3.06	0.44	0.87	0.00	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	151.98	8.07	8.88	3.23	2.69	0.27	1.61	0.27	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	190.69	22.68	8.20	8.90	4.36	0.00	1.57	1.40	3.66
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	222.19	8.42	12.20	7.15	1.68	0.00	3.79	0.42	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	180.40	19.84	7.35	7.16	2.02	0.37	2.76	1.84	3.86
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	221.58	11.27	9.16	7.75	3.52	1.06	1.76	0.70	4.58
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	263.67	11.85	7.46	4.83	2.19	0.00	2.19	0.44	4.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	152.05	19.01	5.06	9.24	3.66	0.70	2.79	1.92	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	188.44	18.96	4.83	13.38	5.58	0.37	2.60	2.60	5.20
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	315.78	8.84	10.78	3.45	1.72	0.43	0.43	1.51	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	136.77	14.33	6.55	8.60	0.82	0.00	3.28	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	302.03	7.65	9.50	3.94	1.39	0.70	1.16	0.70	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	297.18	6.26	9.51	3.25	1.39	0.00	0.46	0.46	2.09
CD14+CD16+ Monocytes, donor1	11789-124B7	275.51	8.28	11.55	1.53	1.74	1.09	1.31	0.65	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	253.63	8.55	12.01	2.08	1.15	0.46	0.00	0.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	216.40	3.47	10.83	0.65	0.43	0.43	1.30	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	301.63	11.21	15.42	2.02	1.40	1.87	0.93	0.62	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	254.98	5.06	12.05	1.05	1.05	0.35	0.87	0.70	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	606.92	14.72	24.97	11.59	3.57	2.23	0.89	1.34	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	158.46	2.30	7.66	0.77	0.26	0.26	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	215.39	6.37	9.66	1.10	1.32	0.66	1.10	0.88	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	236.02	4.21	8.63	0.84	0.63	0.63	0.84	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	400.37	4.06	10.16	0.00	0.00	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	381.02	7.46	8.81	1.36	0.68	1.36	0.00	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	351.07	3.11	5.18	1.04	1.04	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	441.36	7.46	5.86	0.53	1.60	1.60	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	568.77	7.50	10.72	1.07	0.54	2.68	1.07	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	410.63	2.81	7.02	2.11	0.00	0.70	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	364.72	3.14	10.98	0.00	0.00	1.57	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	409.99	5.27	3.95	1.32	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	508.76	33.70	21.37	9.04	4.93	0.00	2.47	3.29	4.11
CD19+ B Cells, donor2	11624-122B4	549.15	18.86	26.12	10.88	3.63	2.18	2.90	2.90	5.80
CD19+ B Cells, donor3	11705-123B4	557.83	19.18	25.75	7.57	6.06	2.02	2.02	3.03	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1057.42	18.59	10.91	7.68	2.83	3.23	2.83	2.42	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	589.25	7.99	5.99	2.00	1.20	0.80	1.60	0.80	0.80
CD34+ Progenitors, donor1	11545-120B6	309.25	2.01	18.07	0.00	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	396.64	1.12	20.23	1.12	0.00	1.69	1.12	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	904.82	8.27	11.27	3.76	0.75	9.02	2.63	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	949.96	4.74	11.27	0.23	2.03	8.34	1.58	1.13	0.68
CD4+ T Cells, donor1	11225-116C1	1001.90	31.78	38.21	9.64	3.93	2.50	2.50	3.93	5.00
CD4+ T Cells, donor2	11306-117C1	497.85	58.79	26.33	21.43	12.86	1.22	4.90	4.90	4.90
CD4+ T Cells, donor3	11382-118B5	511.17	47.58	21.65	17.08	8.54	0.30	6.40	6.71	5.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	409.14	12.76	13.02	3.57	1.28	5.10	1.79	1.02	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	455.48	6.29	10.33	0.67	0.67	3.82	1.12	0.45	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	377.15	6.32	7.47	1.44	0.57	2.01	0.57	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	603.52	13.27	22.76	2.37	1.90	3.79	0.95	1.90	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	502.16	11.24	18.96	1.40	2.11	1.40	3.51	1.40	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	468.06	6.59	26.37	6.59	0.00	6.59	0.00	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	375.88	6.94	11.13	1.88	1.01	1.88	1.16	0.72	1.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	285.21	22.20	8.47	4.91	3.90	1.53	2.88	2.54	2.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	261.96	18.70	8.22	3.55	4.19	1.45	2.42	1.61	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	380.61	8.52	12.10	0.90	0.90	1.79	0.90	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	356.03	6.99	9.78	0.70	0.70	1.05	0.70	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	611.13	15.40	23.76	2.64	2.20	0.44	1.32	2.64	3.96
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	515.67	12.65	17.29	5.90	0.42	3.79	0.84	2.95	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	336.59	26.59	7.48	4.57	3.53	1.87	2.29	3.12	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	269.31	16.04	5.01	4.01	3.34	1.00	0.67	1.67	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	744.01	30.18	20.67	5.71	4.89	5.17	3.81	0.82	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	748.19	11.79	26.80	2.68	3.22	3.75	3.22	2.14	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	570.25	19.73	12.55	10.76	1.79	0.00	1.79	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	587.44	13.91	12.79	2.04	2.41	4.26	2.23	1.67	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	355.47	9.53	9.53	1.73	1.30	2.82	1.08	0.65	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	365.45	5.88	12.82	1.05	1.05	1.68	0.63	1.26	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	402.97	12.64	10.11	2.02	1.01	2.02	1.52	2.02	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	410.29	11.26	11.70	2.17	1.30	3.03	0.43	1.73	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	814.54	20.05	25.28	12.64	3.49	5.67	2.61	1.31	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	569.59	10.39	13.86	1.48	1.98	1.48	1.98	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	405.28	1.85	4.62	0.00	0.00	1.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	393.62	6.98	12.56	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	724.72	3.05	24.65	2.22	1.94	6.37	0.28	0.28	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	788.44	1.47	22.58	3.93	3.68	6.38	0.25	0.74	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	580.58	3.08	12.32	1.54	0.00	0.00	0.00	0.00	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	590.54	5.37	12.89	1.07	0.00	2.51	0.36	0.36	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	511.06	2.77	8.31	0.00	1.38	1.38	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	832.24	20.63	29.47	8.18	3.27	1.64	2.29	2.62	2.29
CD8+ T Cells, donor2	11307-117C2	408.09	52.94	12.01	16.52	7.88	0.38	6.01	8.63	3.38
CD8+ T Cells, donor3	11383-118B6	584.76	55.80	23.99	17.67	10.35	1.01	9.34	6.31	6.82
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	607.43	19.50	12.16	11.24	5.51	3.90	2.29	3.44	2.75
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	625.71	19.17	10.30	12.70	4.07	2.16	1.68	4.55	2.40
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	683.16	32.56	8.48	15.87	4.10	3.01	6.02	3.28	3.28
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	718.11	22.22	15.91	12.01	4.20	3.60	3.90	1.80	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	516.92	16.08	10.08	11.04	4.56	2.40	0.48	2.16	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	572.78	11.82	9.78	5.46	2.27	3.87	2.05	1.36	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	608.61	17.38	7.17	8.26	2.82	2.61	1.96	1.52	2.61
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	677.75	16.32	7.63	10.53	1.58	1.58	1.32	1.05	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	616.54	20.87	9.85	11.96	3.28	1.64	0.94	2.11	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	652.36	22.64	13.28	13.28	4.23	2.42	1.51	2.42	3.92
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	624.29	26.15	6.97	11.04	4.65	2.03	2.61	2.03	3.49
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	645.30	12.79	9.06	9.06	2.66	1.60	1.60	2.13	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	299.86	2.63	2.63	2.19	0.44	0.44	0.44	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	310.60	2.73	3.64	3.19	0.00	1.37	0.46	2.28	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	269.26	0.00	3.73	0.75	1.49	2.24	2.24	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	525.47	6.84	9.00	5.40	2.16	1.80	1.44	2.52	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	521.93	12.66	9.78	7.19	2.01	2.30	2.30	0.86	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	470.92	10.13	4.71	5.89	2.83	1.41	0.94	2.59	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	793.53	19.65	10.46	14.58	5.07	1.58	2.54	1.90	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	676.64	11.69	8.30	8.00	3.08	2.46	2.15	1.54	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	665.21	12.82	5.13	6.41	2.89	1.92	1.60	1.60	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	611.18	14.53	8.80	10.33	2.29	1.53	1.53	2.68	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	566.72	11.43	5.12	6.70	2.36	1.97	1.18	1.58	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	577.14	18.91	4.54	6.05	0.76	3.03	0.00	4.54	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	342.86	7.23	4.82	7.23	4.01	0.80	0.00	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	304.95	2.10	2.80	8.39	1.40	0.70	2.10	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	378.66	7.01	4.01	5.01	2.00	2.00	0.00	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	243.09	16.45	5.48	47.52	5.48	9.14	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	206.04	7.41	3.95	2.47	2.96	1.48	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	370.52	6.00	4.53	1.26	0.84	2.53	0.42	0.21	0.42
Chondrocyte - de diff, donor1	11261-116G1	328.29	1.73	4.16	2.08	1.04	4.85	1.39	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	173.42	2.49	4.26	0.71	0.00	2.49	0.36	0.36	1.07
Chondrocyte - de diff, donor3	11410-118E6	230.74	20.94	5.35	4.44	4.55	3.98	1.37	1.37	3.19
Chondrocyte - re diff, donor2	11339-117F7	803.94	4.48	21.49	2.69	0.90	17.01	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	154.48	4.85	5.66	0.00	1.21	1.62	0.81	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	631.17	16.75	11.36	3.79	3.67	4.82	1.72	0.92	2.30
Ciliary Epithelial Cells, donor2	11323-117D9	362.12	25.65	5.13	5.34	4.49	4.28	2.99	2.14	4.06
Ciliary Epithelial Cells, donor3	11399-118D4	386.03	26.99	6.02	6.11	4.42	3.98	3.19	2.12	2.39
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	267.77	11.83	9.54	3.12	2.11	2.75	1.19	0.83	1.74
Corneal Epithelial Cells, donor1	11526-119I5	85.85	1.54	0.44	0.00	0.00	0.44	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	113.76	6.83	0.00	1.14	0.00	0.00	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	164.37	7.92	2.05	1.28	2.05	0.77	1.53	1.02	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	234.27	4.29	4.95	1.16	0.50	0.33	0.66	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	213.85	3.15	4.73	1.26	0.00	0.32	0.63	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	238.10	6.90	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	150.65	10.26	5.29	2.27	2.59	0.76	0.86	0.54	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	545.94	9.57	26.65	2.39	1.71	0.68	1.02	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	570.61	3.26	32.64	0.65	0.00	0.65	0.00	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	463.62	1.94	34.36	0.97	0.48	0.48	0.00	1.45	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	238.15	2.00	3.50	0.50	0.17	3.00	0.33	0.67	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	177.21	3.52	2.93	1.17	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	312.77	7.07	3.68	3.96	1.41	1.13	0.28	1.13	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	227.65	2.75	3.54	1.18	0.00	2.75	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	282.15	8.44	4.65	1.45	1.16	2.33	1.16	1.16	0.87
Endothelial Cells - Artery, donor2	11341-117F9	532.43	33.88	9.18	6.59	7.29	4.00	3.06	4.94	5.65
Endothelial Cells - Artery, donor3	11413-118E9	328.70	8.59	4.91	1.40	1.58	1.05	0.35	1.23	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	342.01	3.99	8.64	1.55	0.44	3.99	0.00	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	388.24	3.96	8.22	1.22	1.22	2.74	0.00	0.91	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	440.05	3.38	10.15	2.26	0.56	3.38	0.00	0.85	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	182.14	0.59	5.94	2.08	1.19	1.19	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	184.32	1.04	1.04	2.60	1.04	3.12	0.00	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	96.84	8.08	2.84	2.27	2.41	0.85	1.13	0.28	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	920.28	2.40	14.80	3.60	3.20	7.20	0.80	2.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	138.89	6.29	3.67	1.57	1.05	0.52	0.00	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1290.17	29.20	13.79	7.45	3.48	5.96	4.47	2.98	3.60
Endothelial Cells - Umbilical vein, donor2	11324-117E1	691.33	20.64	6.95	4.13	5.87	3.91	1.74	3.48	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	933.42	23.57	9.28	5.37	5.37	3.66	3.42	3.54	2.32
Endothelial Cells - Vein, donor1	11267-116G7	137.64	0.00	1.14	2.28	0.00	0.00	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	137.60	0.70	2.10	0.00	1.40	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	225.93	11.15	3.93	2.04	2.67	1.41	2.04	0.79	0.63
Eosinophils, donor1	12244-129H3	533.64	0.00	45.74	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	290.45	1.65	1.65	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	224.71	3.57	3.57	0.00	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	83.07	2.44	0.49	1.22	0.00	0.24	0.49	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	178.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	218.80	9.44	9.85	3.28	2.87	2.05	1.64	0.00	3.69
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	104.23	2.96	3.18	1.86	0.77	2.08	0.22	0.99	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	157.20	4.12	3.68	1.08	1.08	2.28	0.11	0.43	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	504.65	22.68	9.94	4.37	3.88	6.55	2.43	2.18	1.70
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	686.18	10.92	17.33	3.68	2.46	10.92	0.82	0.68	1.77
Fibroblast - Aortic Adventitial, donor2	11326-117E3	243.84	16.24	4.54	5.38	4.32	3.06	1.69	1.79	2.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	487.19	4.74	12.65	6.06	6.85	7.38	2.11	1.58	3.69
Fibroblast - Aortic Adventitial, donor3	11401-118D6	411.26	23.92	7.97	8.64	2.99	4.98	2.99	2.66	2.33
Fibroblast - Cardiac, donor1	11268-116G8	238.61	9.98	4.54	1.81	2.27	3.63	0.45	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	156.14	1.52	4.55	0.76	0.76	0.76	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	205.98	12.93	6.31	2.05	3.31	3.00	0.79	1.42	1.10
Fibroblast - Cardiac, donor4	11452-119A3	776.26	1.82	12.12	0.61	1.52	4.24	0.61	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	302.79	5.71	6.09	3.55	2.54	2.66	0.89	1.27	1.14
Fibroblast - Cardiac, donor6	11460-119B2	423.40	4.24	5.15	1.67	2.73	1.97	0.76	1.82	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	185.31	0.27	4.29	0.27	0.27	2.41	0.27	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	226.93	10.35	3.02	4.31	2.16	1.73	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	492.17	48.34	8.79	11.72	4.39	4.39	7.32	8.79	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	226.26	2.54	3.23	1.61	0.23	1.38	0.00	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	383.14	11.70	5.94	2.54	1.70	3.05	0.68	0.68	1.19
Fibroblast - Dermal, donor1	11269-116G9	358.51	14.09	5.63	3.05	3.52	5.63	1.17	0.70	1.64
Fibroblast - Dermal, donor2	11346-117G5	394.32	3.30	5.66	1.89	0.00	2.83	0.47	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	373.05	39.17	7.13	7.86	7.62	7.13	3.75	2.90	3.99
Fibroblast - Dermal, donor4	11450-119A1	654.31	9.95	5.65	4.07	6.33	4.63	1.13	2.94	0.90
Fibroblast - Dermal, donor5	11454-119A5	681.24	6.98	6.28	2.27	3.84	4.19	0.87	2.27	0.87
Fibroblast - Dermal, donor6	11458-119A9	827.87	8.45	8.77	4.87	6.66	4.87	1.79	4.39	1.30
Fibroblast - Gingival, donor1	11237-116D4	671.54	9.79	8.75	1.25	1.04	8.75	0.83	1.67	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	422.87	10.22	8.91	3.14	1.83	5.24	2.10	1.57	1.05
Fibroblast - Gingival, donor2	11318-117D4	543.08	56.93	5.27	11.86	10.54	4.88	7.91	4.61	5.27
Fibroblast - Gingival, donor3	11394-118C8	490.11	16.82	8.90	3.29	3.00	5.32	1.16	3.00	1.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	286.73	4.16	8.31	3.12	3.12	9.35	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	177.44	18.85	3.88	4.41	5.99	2.64	2.64	1.23	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	590.07	25.10	8.57	7.79	3.59	4.37	2.81	1.56	2.49
Fibroblast - Gingival, donor6 (control)	11922-125H5	464.51	12.44	7.03	4.19	2.98	3.38	2.30	1.49	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	123.86	0.00	1.76	0.00	0.35	3.18	0.00	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	433.32	13.60	4.68	4.24	1.61	3.80	1.90	1.02	1.75
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	577.32	18.95	10.09	7.91	3.00	5.18	2.32	2.05	3.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	816.99	26.87	8.56	6.36	3.84	6.14	5.05	2.08	3.18
Fibroblast - Gingival, donor9 (control)	11927-125I1	218.79	7.34	5.28	1.03	0.44	3.37	0.29	0.29	0.59
Fibroblast - Lung, donor1	11270-116H1	87.00	0.00	2.72	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	575.97	10.45	4.48	5.97	0.00	4.48	0.00	1.49	2.98
Fibroblast - Lung, donor3	11419-118F6	382.61	13.30	7.60	2.95	1.90	5.06	1.48	2.11	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	329.88	0.83	2.50	0.00	0.00	2.50	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	81.12	0.00	0.00	0.00	0.00	2.80	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	32.75	0.56	0.56	0.00	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	565.51	2.84	5.28	1.22	0.81	2.44	0.81	0.41	0.81
Fibroblast - Mammary, donor2	11620-122A9	127.81	0.00	3.99	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	208.47	0.00	0.00	5.96	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	754.75	21.92	7.18	6.01	3.10	5.63	1.94	1.94	2.13
Fibroblast - Periodontal Ligament, donor2	11319-117D5	879.91	41.56	8.65	5.31	12.74	6.07	2.88	9.25	3.79
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1560.23	8.57	14.69	2.75	2.14	18.97	0.61	0.31	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	357.96	8.40	5.72	1.91	2.29	6.11	1.14	1.14	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	241.37	12.69	3.78	1.62	3.78	4.05	1.08	1.08	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	174.54	6.26	5.57	1.16	1.74	2.09	1.04	0.46	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	494.85	14.04	5.08	2.98	1.44	4.20	1.44	1.55	1.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	240.58	1.22	2.03	0.41	0.00	1.22	0.00	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	175.74	2.67	2.00	1.34	0.00	2.00	0.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	240.78	8.70	5.54	2.37	0.79	3.56	0.79	0.40	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	784.66	9.92	10.91	20.04	8.73	5.56	5.16	3.97	4.96
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	338.19	8.88	6.22	5.51	2.31	2.84	0.89	1.78	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	510.06	15.37	8.47	5.72	2.76	3.55	2.56	1.97	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	541.24	4.51	6.02	9.03	3.91	4.81	1.50	0.60	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	628.60	3.99	13.06	4.86	2.37	9.82	0.97	0.86	1.84
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	505.64	4.30	16.20	7.59	5.06	6.33	2.28	2.53	2.28
Fibroblast - skin normal, donor1	11553-120C5	345.71	6.23	5.91	4.27	1.80	5.91	0.66	0.82	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	968.05	22.26	12.03	9.62	5.01	7.82	3.81	1.80	4.61
Fibroblast - skin normal, donor2	11561-120D4	438.12	2.71	9.04	3.32	2.71	7.03	0.80	0.70	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	761.64	9.37	13.90	13.90	8.46	5.74	5.14	1.81	4.53
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	436.35	6.88	8.62	2.07	0.99	3.31	0.58	0.50	1.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	426.86	3.25	11.97	4.44	2.56	7.01	1.54	1.54	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	437.47	2.63	9.85	7.55	4.60	7.55	1.31	0.00	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	476.37	1.38	9.16	4.79	1.92	7.99	0.85	0.75	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	429.97	16.36	7.08	4.22	4.05	3.54	1.35	2.36	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	195.40	6.90	4.39	1.41	2.20	4.55	0.47	0.47	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	8487.20	576.15	243.76	221.60	221.60	155.12	44.32	66.48	88.64
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	303.29	13.94	6.97	5.23	3.49	6.10	0.87	4.36	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	329.21	5.37	3.81	1.21	1.39	1.91	0.17	0.87	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	510.07	8.59	6.25	2.60	2.08	2.60	0.26	1.04	2.60
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	586.66	9.45	6.90	1.79	1.79	3.58	1.28	0.00	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	551.96	12.25	4.59	3.83	1.53	3.83	0.00	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	764.41	21.06	3.83	3.83	6.38	1.91	0.64	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1136.21	89.86	12.27	24.53	15.69	2.85	12.55	6.28	11.70
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	379.99	33.64	5.52	11.86	7.45	1.10	6.34	3.31	3.03
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	367.15	27.17	5.71	8.90	6.16	1.37	2.97	2.51	3.20
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	743.98	46.76	5.15	13.27	8.72	3.37	6.54	4.95	4.95
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	369.54	26.43	4.76	7.67	3.17	0.79	2.38	4.49	3.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	317.01	15.66	6.85	6.20	4.57	1.63	1.30	2.28	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	920.71	88.44	9.73	27.42	14.59	3.54	12.38	4.86	15.92
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	980.49	55.68	9.19	16.39	10.18	3.53	4.80	3.82	6.50
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	646.00	37.56	7.63	11.70	9.24	2.96	4.93	3.45	4.56
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	777.40	59.10	5.64	17.19	9.67	2.95	4.84	5.91	5.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	521.96	26.64	6.07	7.31	4.34	2.35	2.97	2.11	2.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	581.53	34.47	7.61	9.14	5.81	1.94	4.15	2.91	3.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	626.17	50.01	7.32	13.01	9.35	3.66	5.29	3.86	3.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	402.28	21.91	5.70	5.70	5.02	2.74	1.60	2.28	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	439.47	34.50	5.23	8.22	6.60	3.36	3.74	3.11	1.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	381.20	23.39	4.15	5.46	4.81	1.31	3.50	1.53	4.15
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	414.56	26.89	4.43	4.73	5.91	2.07	2.07	2.36	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	558.42	42.28	8.74	10.65	8.11	1.43	4.45	3.81	4.13
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	382.72	21.90	2.68	5.36	3.57	1.12	1.56	1.12	2.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	515.58	40.53	8.67	11.29	7.26	2.82	3.43	3.83	3.83
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	655.50	53.95	12.04	11.71	11.54	2.88	5.09	1.87	5.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	855.69	17.20	10.02	5.76	1.95	3.72	1.33	1.60	3.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	796.45	8.84	13.42	4.27	0.73	4.68	1.35	0.73	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	810.33	6.49	10.08	4.10	0.68	6.66	0.51	1.71	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	544.31	29.43	13.39	7.41	5.53	2.32	2.88	2.55	3.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	753.84	14.06	11.23	4.74	2.75	4.49	1.08	0.83	1.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	711.77	8.58	8.78	3.06	1.02	3.68	0.41	0.61	2.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	429.12	28.68	9.49	6.19	4.54	1.65	1.86	1.65	2.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	520.66	29.98	10.38	8.07	5.30	2.42	2.88	2.42	4.73
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	443.59	29.18	7.17	5.34	7.34	3.84	2.67	3.00	2.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	341.45	20.94	5.73	7.27	4.63	2.65	2.20	2.42	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	530.34	33.70	7.13	6.89	5.90	2.71	3.94	1.48	3.69
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	458.07	31.61	6.32	8.59	7.46	2.27	4.38	2.92	3.24
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	408.27	39.45	5.45	8.98	9.30	1.28	2.57	3.21	3.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	374.37	22.55	8.53	5.40	4.55	1.52	2.27	1.80	3.51
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	393.70	32.43	6.80	6.49	4.75	2.37	3.16	2.85	2.06
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	444.27	37.71	6.99	7.91	5.47	3.04	0.30	3.04	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	422.96	25.40	8.68	7.21	5.23	2.82	2.93	1.78	3.55
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	331.09	22.83	5.27	4.39	3.51	2.20	2.20	1.98	3.51
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	359.94	35.91	8.98	5.61	6.73	0.84	2.52	2.52	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	332.11	13.52	6.57	4.63	1.57	2.13	2.96	0.09	3.33
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	403.24	25.94	7.75	9.09	4.81	4.55	1.87	1.87	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	413.27	31.52	6.27	8.57	4.59	3.52	1.22	1.84	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	337.83	19.17	8.55	7.25	4.66	2.33	2.98	1.81	2.98
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	315.53	9.76	4.07	2.17	1.63	1.90	1.36	1.36	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	338.65	28.21	6.82	9.59	4.98	3.32	2.21	2.58	2.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	332.48	21.27	6.14	5.92	2.19	1.54	2.19	1.10	2.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	725.96	16.86	10.91	5.95	1.98	0.99	0.00	2.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	293.24	18.07	6.07	2.90	2.51	2.64	1.71	1.06	1.71
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	240.29	15.13	3.23	3.83	1.82	1.41	1.82	2.82	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	1033.67	3.30	25.42	3.05	0.51	5.85	0.00	1.02	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1682.46	13.74	11.74	21.50	9.95	12.34	4.98	4.18	2.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	984.09	66.41	7.86	17.72	13.25	4.01	7.24	4.62	6.63
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1594.93	77.13	13.50	23.32	12.48	6.14	11.25	6.14	9.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	651.83	7.51	5.95	0.94	1.25	1.88	1.56	1.88	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	701.59	7.06	5.37	0.57	0.57	1.70	1.70	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	880.44	23.98	7.38	11.99	7.38	4.15	4.15	5.07	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	814.21	37.12	0.00	14.85	9.90	4.95	4.95	0.00	12.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	909.77	38.68	10.83	9.28	10.44	2.71	2.32	3.87	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	651.41	36.90	4.81	8.02	6.42	6.42	4.81	8.02	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	606.85	74.77	5.22	19.13	13.91	1.74	1.74	6.96	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	684.16	27.01	4.23	10.09	4.23	3.91	1.30	3.91	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	936.03	53.53	12.35	15.65	10.71	4.94	7.82	7.00	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1286.26	173.28	13.33	66.65	26.66	0.00	26.66	23.33	16.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	646.27	26.85	6.43	7.55	5.87	3.64	4.19	3.08	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	760.56	35.63	9.48	10.79	6.86	3.27	5.23	4.25	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	817.03	93.95	11.74	20.97	15.10	2.52	14.26	10.90	18.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	694.03	29.26	11.45	6.04	7.32	0.95	3.50	4.45	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	704.12	28.87	9.17	7.81	7.13	3.06	2.72	3.06	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	480.27	27.15	8.35	4.18	6.26	0.00	6.26	4.18	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	754.82	24.63	13.17	6.87	3.44	3.44	2.86	6.30	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	536.32	28.71	6.81	7.10	5.92	1.78	6.22	4.14	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	659.02	59.30	13.55	22.02	11.86	0.00	11.86	10.16	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	840.84	54.26	14.91	12.01	10.36	2.07	5.80	12.01	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	791.41	35.21	9.44	9.67	8.98	3.45	4.60	5.29	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	368.79	5.27	5.27	0.00	0.00	0.00	5.27	10.54	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	550.09	27.29	8.84	7.30	6.92	3.84	2.69	3.08	3.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	484.72	23.14	7.82	7.17	3.26	0.98	1.96	2.61	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	282.92	7.36	3.34	4.01	0.67	0.67	1.34	2.68	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	651.49	29.28	11.56	7.71	6.55	3.08	1.93	2.70	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	928.08	41.77	9.59	13.35	10.27	5.14	7.53	6.50	5.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	464.66	62.12	2.48	22.36	7.45	0.00	2.48	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	474.21	21.23	6.13	6.13	3.30	0.47	2.36	3.77	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	519.00	32.59	9.05	5.43	6.03	3.02	4.22	4.83	3.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	550.39	11.19	3.56	6.10	3.05	3.05	2.03	2.03	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	628.17	35.90	9.57	9.17	7.58	4.79	1.60	3.59	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	577.72	30.09	8.88	5.92	5.92	1.48	1.97	3.45	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	531.20	22.43	5.90	10.62	2.36	1.18	5.90	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	437.58	21.00	6.42	5.25	4.08	4.08	2.33	2.92	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	461.27	18.87	3.95	6.58	1.32	1.32	3.51	3.51	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	485.73	30.52	6.78	9.32	7.63	0.85	5.93	5.09	9.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	414.26	22.68	7.16	2.98	3.58	1.19	3.58	1.79	4.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	463.41	17.95	12.62	5.82	3.40	0.00	2.43	2.91	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	94.73	1.14	1.14	0.00	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	193.77	25.78	2.49	2.08	3.33	2.91	2.91	1.66	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	89.96	1.12	0.00	1.12	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	281.96	15.22	2.22	6.03	2.85	4.76	2.22	2.22	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	188.82	8.35	2.09	1.25	2.92	3.76	0.84	0.42	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	701.82	47.46	11.49	13.00	9.98	4.87	5.69	5.80	4.99
Hep-2 cells mock treated, biol_rep2	11899-125E9	743.40	47.26	10.47	12.66	10.47	5.40	5.91	4.56	3.88
Hep-2 cells mock treated, biol_rep3	11900-125F1	789.21	48.23	10.24	15.93	10.24	5.92	4.55	8.65	5.01
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	661.87	50.83	13.34	12.35	10.28	4.15	4.26	5.14	6.34
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	678.05	38.25	13.11	9.46	8.81	4.30	4.08	3.01	4.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	730.02	46.29	9.04	11.84	7.97	4.31	4.95	6.46	2.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	558.68	47.20	8.09	10.83	10.46	4.61	5.98	4.11	3.99
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	578.81	31.39	8.58	11.15	5.83	4.29	3.60	5.32	4.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	594.29	31.72	5.45	14.10	7.05	6.41	6.73	3.84	3.52
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	92.34	0.00	2.24	0.00	1.12	0.56	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	67.52	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	526.12	21.15	7.93	21.15	10.58	0.00	7.93	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	105.82	2.12	2.12	0.35	0.71	0.35	0.35	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	63.93	2.91	0.73	0.00	0.00	1.45	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	361.22	17.48	5.77	3.15	5.07	2.97	2.27	2.27	1.92
Hepatocyte, donor1	11523-119I2	315.97	20.58	4.84	15.74	3.63	1.21	0.00	3.63	0.00
Hepatocyte, donor2	11603-120I1	356.60	20.47	2.15	10.77	2.15	2.15	3.23	3.23	1.08
Hepatocyte, donor3	11684-122I1	352.17	50.92	4.91	25.77	13.50	3.07	4.91	3.68	4.91
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	747.33	35.90	5.22	9.14	6.53	7.18	4.57	1.96	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	558.08	15.38	4.54	3.85	2.10	2.27	1.92	1.92	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	468.01	14.82	7.96	3.43	2.74	6.31	1.65	2.06	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	108.25	0.00	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	128.75	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	80.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	261.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	105.08	0.00	2.56	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	157.56	4.87	4.87	3.25	0.00	0.00	0.00	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	113.38	5.00	0.00	3.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	119.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	117.79	3.97	0.00	1.32	1.32	1.32	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	139.69	4.43	1.11	0.00	1.11	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	110.00	0.00	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	175.73	3.78	3.15	0.63	0.00	1.26	0.00	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	128.37	1.55	4.64	0.00	1.55	0.00	0.00	3.09	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	135.02	3.23	0.65	1.94	0.65	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	111.08	0.00	1.61	1.61	3.22	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	140.16	4.07	0.81	0.81	1.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	113.77	0.42	1.26	0.00	0.42	0.84	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	129.35	0.00	14.37	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	168.77	3.21	2.41	0.80	2.41	2.41	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	126.49	3.69	0.92	1.85	0.00	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	152.94	7.55	1.42	1.42	0.47	0.00	0.47	0.00	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	138.77	2.72	1.81	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	126.98	7.53	1.08	1.08	2.15	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	134.67	1.27	1.27	0.00	1.27	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	141.56	2.55	1.28	1.28	0.64	1.28	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	123.94	0.00	3.65	0.00	0.00	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	142.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	154.24	5.00	2.14	0.71	1.43	0.00	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	126.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	173.47	8.03	1.23	2.16	1.23	0.62	0.31	1.54	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	149.26	3.51	1.76	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	157.16	0.00	0.00	0.00	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	137.69	1.39	0.70	1.39	0.70	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	4.43	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	116.71	3.24	3.24	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	66.27	0.87	0.00	0.00	1.74	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	51.75	0.00	4.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	97.57	3.48	0.00	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	61.87	1.07	2.13	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	105.29	2.77	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	151.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	94.80	3.68	0.00	0.00	0.00	1.84	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	36.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	37.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	598.20	13.79	8.89	4.24	1.31	3.43	0.98	1.88	2.20
Keratinocyte - epidermal, donor2	11349-117G8	105.41	0.59	1.17	1.17	0.59	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	604.00	61.05	7.67	16.47	11.93	4.07	7.00	3.69	7.95
Keratinocyte - oral, donor1	11251-116E9	899.74	42.57	9.54	10.78	6.36	7.61	3.97	3.41	3.97
Keratocytes, donor1	11527-119I6	192.55	0.69	2.06	0.00	0.34	0.34	0.34	0.34	0.69
Keratocytes, donor2	11607-120I5	127.73	2.34	0.00	1.17	0.00	0.00	0.00	2.34	0.00
Keratocytes, donor3	11688-122I5	329.20	21.74	6.32	4.15	5.73	2.57	2.77	2.37	3.36
Krukenberg tumor cell line:HSKTC	10687-109F3	389.03	6.59	6.59	0.00	2.20	4.40	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	340.88	14.02	4.31	11.87	1.08	3.24	5.39	4.31	5.39
Lens Epithelial Cells, donor2	11609-120I7	443.80	8.42	8.30	2.54	1.85	2.19	0.69	0.23	2.31
Lens Epithelial Cells, donor3	11690-122I7	381.64	5.05	8.78	1.41	0.71	7.87	0.20	0.50	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	306.17	10.79	4.39	2.85	1.66	1.90	1.42	0.83	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	162.70	14.51	3.07	5.86	2.51	2.23	1.67	0.84	3.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	284.76	38.25	7.71	14.32	6.45	2.05	6.61	3.62	5.51
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	185.51	9.68	3.23	2.69	0.54	0.54	1.08	1.08	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	127.96	10.09	4.10	3.78	0.95	1.58	1.58	0.95	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	139.19	13.48	2.59	3.77	2.16	0.11	3.02	1.40	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	215.87	15.18	3.28	6.57	4.10	2.05	1.64	0.41	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	87.73	8.09	2.53	2.02	0.51	1.01	0.51	0.76	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	177.49	27.31	5.63	8.45	5.07	1.41	5.21	2.39	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	195.00	10.28	3.96	3.56	2.77	0.40	1.98	0.40	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	177.02	15.90	3.68	4.46	3.30	1.55	2.71	1.94	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	55.91	5.18	1.11	0.93	0.74	0.56	1.30	0.56	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	175.95	14.63	3.48	3.83	2.44	1.74	2.44	1.39	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	175.31	9.78	3.58	2.86	2.39	0.72	1.19	1.43	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	144.08	18.13	3.02	3.30	3.02	0.69	2.88	1.51	1.37
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	219.88	20.02	6.47	5.24	2.77	4.00	3.08	0.00	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	104.75	7.79	2.49	0.31	1.56	0.62	0.94	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	155.18	18.30	2.38	5.49	4.03	0.55	2.38	1.28	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	201.74	16.13	2.63	4.94	3.95	1.32	2.96	2.30	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	117.73	10.25	2.05	2.34	2.05	0.29	0.88	0.88	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	105.55	5.48	2.49	2.49	1.49	0.25	0.75	1.24	2.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	233.27	15.52	4.36	5.82	1.45	1.45	2.91	2.42	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	184.20	16.97	3.50	5.39	1.35	2.42	1.62	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	169.85	16.95	5.30	5.30	3.48	0.76	2.27	1.36	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	177.30	12.96	3.11	5.18	1.04	4.15	1.56	0.52	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	220.70	20.73	5.03	3.77	2.93	1.88	2.72	1.26	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	146.61	13.08	3.91	3.76	2.86	1.20	1.95	1.50	2.11
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	181.60	11.69	2.06	1.38	0.00	2.75	2.06	1.38	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	166.70	9.03	4.52	3.95	2.45	1.32	2.07	1.69	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	120.77	14.74	3.82	2.65	3.18	0.95	1.48	1.17	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	197.71	14.05	5.33	3.39	0.97	0.97	1.45	2.42	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	157.46	9.26	3.97	2.32	1.32	1.32	1.32	0.66	2.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	128.35	14.00	4.83	3.96	2.35	0.99	1.86	1.36	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	266.92	13.70	7.40	3.33	1.48	2.22	1.48	1.85	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	168.76	11.86	3.71	3.21	1.24	0.99	1.98	0.74	3.71
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	104.77	11.41	3.16	3.85	2.61	0.96	1.92	1.79	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	199.74	13.19	5.15	3.54	2.57	1.61	2.57	0.32	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	243.77	15.52	4.26	4.26	2.43	1.83	3.04	1.83	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	215.97	26.31	4.90	5.32	3.64	2.10	3.08	2.38	1.96
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	199.11	11.38	4.62	5.33	3.56	1.42	2.13	2.13	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	104.23	4.85	1.94	2.42	1.45	1.45	1.45	0.48	1.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	94.45	7.47	2.65	1.71	0.78	0.31	0.78	0.93	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	154.70	10.03	3.94	2.86	2.15	0.36	2.15	0.00	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	153.86	3.27	1.96	0.98	0.65	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	73.45	6.12	1.88	2.83	1.41	0.00	1.18	0.71	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	340.19	12.50	5.45	1.98	1.49	2.10	0.99	1.24	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	92.46	7.94	2.56	0.77	2.31	0.26	1.54	0.00	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	140.23	12.53	3.58	4.48	2.98	0.60	0.60	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	135.96	4.53	2.27	0.00	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	104.33	5.37	0.77	3.84	3.07	0.00	0.77	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	130.63	3.71	0.74	0.00	1.48	0.74	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	158.25	14.39	5.50	1.27	1.27	0.42	1.27	1.69	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	115.35	4.92	2.11	0.70	3.52	0.00	0.00	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	117.68	4.67	1.87	0.93	0.93	0.93	0.00	1.87	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	148.91	14.94	3.61	6.18	0.52	0.52	1.03	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	93.97	2.38	0.00	1.19	0.00	0.00	0.00	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	161.95	2.26	3.62	0.45	1.13	0.68	0.68	0.23	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	271.63	22.68	10.76	3.78	3.20	1.16	1.16	2.33	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	279.56	15.31	8.10	7.65	4.95	4.50	0.90	0.90	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	227.48	4.88	4.06	0.81	0.68	2.71	0.41	0.27	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	149.44	7.70	5.65	2.05	2.57	0.51	1.54	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	234.65	7.41	6.35	4.59	1.41	2.47	0.35	2.82	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	215.88	7.33	6.66	2.00	2.00	2.00	2.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	182.87	12.23	7.64	2.04	1.53	0.00	1.53	1.53	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	280.41	13.34	7.47	4.80	4.80	1.60	1.07	1.87	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	323.10	17.57	9.07	4.16	4.16	2.83	3.21	2.65	2.46
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	158.91	9.82	1.84	2.45	1.23	1.23	0.00	2.45	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	193.26	7.34	1.63	3.26	3.26	1.63	2.45	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	355.05	21.87	8.12	6.46	6.46	2.92	2.50	2.50	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	282.22	17.94	10.65	5.04	3.36	2.52	2.52	2.24	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	166.92	5.15	2.06	1.03	0.00	0.00	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	300.75	24.10	9.29	4.64	7.26	3.48	1.45	4.06	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	254.39	10.76	7.47	3.89	3.59	0.90	1.49	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	242.33	8.30	6.64	2.77	4.98	3.32	1.11	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	206.08	13.43	6.36	4.60	2.83	1.41	0.71	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	207.62	11.06	4.79	3.69	2.58	1.84	1.11	1.84	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	111.67	5.76	8.06	1.15	3.45	0.00	0.00	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	163.86	10.75	5.76	2.30	0.77	0.77	1.92	1.15	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	166.44	16.98	5.10	2.26	1.70	0.00	1.70	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	164.09	4.92	7.38	0.82	3.28	0.00	0.00	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	153.19	8.59	2.71	2.71	4.07	1.36	0.90	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	177.38	12.21	2.87	2.15	2.15	2.87	0.72	1.44	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	186.73	5.23	8.22	0.75	0.75	2.99	0.75	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	189.88	15.98	5.20	4.83	4.83	1.49	1.11	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	230.45	14.65	7.75	6.46	2.15	1.29	0.86	1.29	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	166.98	8.56	3.43	2.57	1.71	1.71	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	229.89	14.66	5.33	3.66	1.33	0.67	0.67	1.67	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	147.21	9.65	2.41	3.62	1.81	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	100.25	1.42	1.42	2.13	0.71	1.42	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	147.11	12.03	3.44	2.06	2.06	0.34	1.03	1.03	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	156.73	5.90	2.68	2.68	1.07	1.07	0.00	2.15	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	113.80	4.71	2.69	0.67	2.02	2.69	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	188.91	10.00	4.82	4.82	2.96	0.74	1.48	1.85	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	132.57	1.16	3.49	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	70.87	4.23	0.00	1.06	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	174.07	12.00	4.80	2.40	2.80	0.80	1.60	2.80	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	98.13	2.18	4.36	1.45	0.00	0.00	0.73	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	108.85	2.30	3.83	1.53	1.53	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	159.33	9.87	2.96	2.96	0.49	1.48	0.49	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	145.84	8.47	4.70	0.94	0.94	0.94	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	111.12	6.54	1.51	2.01	2.01	0.50	0.00	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	167.18	8.56	4.06	0.90	3.15	2.25	0.90	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	154.90	10.33	5.16	1.72	1.72	5.16	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	159.43	7.13	4.01	3.12	1.34	3.12	0.89	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	181.83	5.47	2.74	3.91	1.96	0.78	0.39	1.56	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	151.08	10.56	3.96	2.64	2.64	0.66	0.66	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	122.47	7.78	2.08	2.59	2.08	0.52	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	217.03	21.44	5.69	3.94	4.38	0.88	0.88	2.63	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	213.02	9.50	3.91	5.59	2.80	1.68	1.68	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	155.46	9.72	3.53	0.44	0.44	0.44	0.88	1.32	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	215.23	12.34	6.94	4.24	3.09	0.39	0.77	1.93	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	185.83	7.60	4.56	3.54	1.52	1.01	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	175.91	12.02	3.36	1.92	1.44	2.88	1.44	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	201.95	18.29	4.37	6.36	1.59	0.40	1.59	2.39	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	179.25	6.68	4.25	4.86	3.04	0.61	1.82	2.43	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	141.11	0.69	2.08	0.69	0.69	2.77	0.00	0.69	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	203.68	12.92	3.04	2.66	1.14	1.14	0.76	2.28	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	193.14	9.30	5.68	1.03	2.07	0.00	1.03	0.52	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	128.19	1.81	4.23	2.42	1.81	1.21	1.81	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	191.09	12.68	6.02	4.12	3.17	1.27	0.95	1.58	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	147.13	5.33	3.20	2.67	0.53	1.07	1.07	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	122.40	0.57	1.15	0.57	2.30	1.15	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	191.81	13.37	3.09	1.03	1.03	0.51	0.51	1.03	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	177.55	13.44	2.83	1.41	3.54	0.00	0.71	2.12	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	130.52	1.13	2.84	1.13	0.00	1.13	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	195.95	8.74	3.33	3.33	2.08	1.25	1.66	1.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	173.05	10.18	5.48	2.35	0.00	0.78	0.78	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	106.06	0.42	5.01	3.76	1.67	0.00	0.00	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	129.63	6.50	2.32	1.39	1.86	0.46	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	151.87	8.70	2.01	2.01	1.34	2.68	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	166.81	3.74	2.67	0.53	2.67	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	194.37	18.18	5.25	2.83	2.83	0.40	0.81	2.83	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	107.38	7.34	0.92	0.00	0.00	0.92	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	127.14	0.89	0.89	3.56	1.78	0.00	0.89	1.78	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	173.24	8.55	5.13	0.00	1.14	1.14	2.28	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	139.58	2.30	2.30	0.77	0.77	0.77	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	224.34	1.64	8.21	2.74	1.64	1.09	2.74	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	163.92	8.02	4.01	1.78	3.12	0.45	0.45	0.89	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	176.51	4.68	2.86	0.52	1.30	0.52	0.26	0.26	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	140.58	0.00	3.32	1.99	1.99	1.33	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	166.29	12.47	6.24	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	203.30	4.10	5.93	0.68	1.82	0.68	0.23	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	224.61	3.85	4.59	1.47	1.10	1.28	0.18	0.18	0.73
Macrophage - monocyte derived, donor3	11389-118C3	177.09	10.09	4.06	1.84	2.49	1.44	2.10	0.79	1.57
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	285.69	4.25	3.19	0.00	0.53	1.59	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	489.78	13.15	7.61	4.91	3.64	3.80	0.95	1.90	1.43
Mallassez-derived cells, donor3	11930-125I4	746.36	12.93	7.92	6.25	2.78	5.00	0.97	2.50	1.53
Mammary Epithelial Cell, donor1	11273-116H4	761.28	43.64	11.56	10.66	6.28	7.07	4.78	2.69	4.19
Mammary Epithelial Cell, donor2	11350-117G9	703.03	23.16	8.11	11.00	4.92	5.21	3.47	3.19	4.05
Mammary Epithelial Cell, donor3	11422-118F9	191.31	4.49	2.00	1.00	0.75	0.25	0.50	0.75	0.50
Mast cell - stimulated, donor1	11487-119E2	5935.33	68.47	134.23	21.69	13.56	42.03	2.03	5.42	14.24
Mast cell, donor1	11563-120D6	534.54	9.52	12.11	6.49	2.05	1.95	1.41	0.65	2.49
Mast cell, donor2	11565-120D8	592.86	5.05	22.88	5.65	1.49	3.86	0.00	0.89	2.38
Mast cell, donor3	11566-120D9	630.12	5.85	22.96	2.25	1.58	3.38	0.90	1.35	1.13
Mast cell, donor4	11567-120E1	602.96	6.56	18.44	2.30	1.42	2.30	0.35	0.35	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	575.42	16.41	16.19	6.76	2.33	7.32	1.89	2.99	2.77
Mast cell, expanded and stimulated, donor8	11942-126A7	686.41	11.09	20.43	3.50	1.17	5.25	1.75	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	347.38	7.00	8.15	1.61	0.80	0.80	0.69	0.69	0.69
Mast cell, expanded, donor8	11941-126A6	392.98	5.86	12.72	2.85	1.00	1.17	0.33	1.00	0.84
Melanocyte - dark, donor1	11502-119F8	459.78	9.25	5.27	2.89	1.39	1.39	1.09	0.99	0.80
Melanocyte - dark, donor2	11582-120F7	229.80	9.34	3.81	1.73	1.73	1.38	0.69	2.42	1.04
Melanocyte - dark, donor3	11663-122F7	657.62	14.20	9.27	4.49	3.19	5.07	1.74	1.30	2.17
Melanocyte - light, donor1	11274-116H5	107.43	1.18	0.71	1.41	0.00	0.94	0.24	0.24	0.71
Melanocyte - light, donor2	11351-117H1	45.73	0.68	0.00	2.05	0.00	0.00	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	60.71	6.07	3.47	0.00	0.00	0.87	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	438.26	23.22	5.21	4.89	5.10	3.64	2.08	2.08	1.35
Melanocyte, donor2 (MC+2)	12739-135I3	276.74	17.75	6.45	6.19	2.69	4.30	1.88	0.81	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	408.48	12.59	9.64	2.95	2.95	2.68	1.07	1.61	1.07
Meningeal Cells, donor1	11493-119E8	493.01	0.74	5.58	1.49	1.12	5.58	0.25	0.00	0.37
Meningeal Cells, donor2	11573-120E7	298.86	1.32	5.28	0.88	3.08	4.84	0.00	0.88	0.00
Meningeal Cells, donor3	11654-122E7	1224.15	31.62	10.27	9.86	3.18	8.97	2.45	3.59	3.26
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	441.99	8.84	5.13	2.00	2.00	3.14	1.14	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	295.36	5.64	8.55	1.71	0.70	5.13	0.50	0.60	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	47.31	1.31	0.00	0.00	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	113.81	2.62	2.62	2.62	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	493.00	45.93	3.59	9.33	6.46	1.44	5.74	4.31	5.02
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	242.47	3.39	8.68	2.96	1.48	1.69	0.85	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	238.25	11.56	3.02	2.51	0.50	4.02	0.50	0.50	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	203.05	3.52	1.54	1.32	1.10	1.54	0.66	0.44	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	166.57	6.58	1.46	3.65	0.73	0.73	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	116.83	4.71	1.64	1.43	0.20	0.82	0.41	0.82	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	283.25	1.52	10.80	1.66	1.39	5.12	0.69	0.69	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	89.96	1.49	0.74	1.86	0.37	0.37	0.74	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	394.85	19.47	7.89	5.26	2.76	1.84	1.45	1.97	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	116.03	2.37	1.48	1.19	1.19	1.19	0.89	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	107.44	2.34	2.34	2.34	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	159.46	7.68	1.92	2.56	1.92	1.92	1.92	1.28	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	686.20	15.24	7.80	1.77	2.13	4.25	2.13	0.35	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	297.71	5.00	5.00	0.63	0.63	1.56	0.94	0.31	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	421.63	16.69	2.90	7.98	2.90	2.18	3.63	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	235.74	5.30	4.51	1.86	0.80	3.18	1.06	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	188.68	2.00	4.50	0.00	1.00	1.50	0.50	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	204.08	25.08	3.97	10.12	4.26	2.38	2.75	2.24	3.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	459.11	14.85	9.45	4.05	0.00	1.35	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	191.85	6.90	8.62	2.22	1.48	1.23	0.49	0.25	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	164.90	8.24	6.18	4.71	1.77	0.59	0.59	1.77	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	93.34	0.00	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	128.32	6.82	3.41	0.31	1.55	1.55	0.31	0.00	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	143.54	9.54	3.73	5.19	2.28	0.83	1.66	1.45	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	118.12	4.63	2.32	4.63	2.32	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	147.40	4.75	5.26	1.75	1.00	0.00	0.75	0.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	173.62	4.65	2.79	2.79	1.86	0.00	1.86	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	136.26	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	136.36	4.67	3.45	1.42	1.02	0.00	0.20	1.22	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	129.88	6.34	3.56	2.38	1.98	1.58	0.79	0.40	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	119.72	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	120.35	5.31	5.31	1.77	2.65	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	148.18	11.02	5.32	3.80	2.28	0.00	0.76	0.00	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	128.96	2.63	1.32	2.63	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	133.49	11.25	3.18	2.55	1.70	0.42	0.85	0.42	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	98.53	1.84	4.60	0.00	0.92	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	123.40	5.96	2.38	1.49	0.89	0.60	0.30	1.19	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	108.98	3.35	1.68	5.03	1.68	1.68	1.68	0.00	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	123.19	6.52	4.01	1.76	1.25	0.00	0.25	0.75	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	140.70	13.31	4.52	2.14	2.61	0.00	2.38	0.24	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	175.82	3.32	1.11	0.00	0.00	1.11	1.11	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	131.93	6.22	2.76	2.30	2.07	0.46	0.69	0.23	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	138.82	10.10	3.58	2.94	0.42	1.05	0.63	0.21	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	119.65	6.73	3.06	1.43	1.22	0.20	0.82	1.02	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	121.64	7.29	3.65	1.50	1.50	1.29	0.00	0.43	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	125.15	6.00	3.78	2.45	0.67	0.89	0.44	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	103.18	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	104.03	5.04	2.19	1.97	0.66	0.22	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	115.59	2.53	3.55	1.01	0.51	1.01	0.00	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	140.84	0.00	0.00	1.66	4.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	127.74	4.89	3.53	2.45	1.36	0.82	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	118.81	3.23	2.94	1.18	0.59	0.59	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	115.57	3.27	4.36	2.18	2.18	1.09	1.09	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	60.55	0.96	2.88	0.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	115.67	8.40	2.40	4.00	2.00	0.40	2.00	0.00	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	167.29	4.11	8.23	1.37	1.37	1.37	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	88.60	5.51	3.00	1.00	1.00	0.50	0.50	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	146.77	0.00	6.12	0.00	0.00	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	119.99	3.07	1.75	0.88	1.75	0.00	0.44	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	84.98	1.10	1.10	0.00	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	163.94	3.84	6.40	0.64	0.00	1.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	168.09	4.96	6.45	0.50	0.99	0.25	0.50	0.00	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	106.47	2.09	2.09	2.09	0.00	0.70	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	194.47	2.21	8.84	2.21	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	147.35	8.89	5.47	1.03	0.68	0.00	1.71	1.37	2.05
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	114.66	1.31	3.94	1.31	0.88	0.44	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	187.85	5.68	9.23	2.49	1.42	1.78	0.36	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	149.53	9.54	6.17	2.81	0.56	0.56	0.56	0.84	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	123.86	3.74	2.91	0.83	0.00	1.25	0.83	0.00	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	145.69	2.91	7.58	1.75	0.58	0.00	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	115.54	5.73	2.41	2.41	1.51	0.00	0.90	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	141.91	5.43	3.76	1.67	0.42	0.42	1.67	0.00	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	144.38	0.00	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	136.69	8.31	6.46	1.85	1.85	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	173.01	5.12	3.98	1.71	0.57	0.57	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	170.38	7.46	7.60	1.52	1.24	0.83	0.83	0.00	1.38
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	116.36	5.70	2.33	1.81	0.78	0.52	0.78	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	170.30	3.43	4.29	1.29	1.29	1.72	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	123.23	0.64	4.45	0.64	0.64	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	122.77	3.74	4.80	2.67	1.33	0.27	0.53	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	120.33	4.79	3.29	3.29	1.20	0.00	0.60	0.00	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	117.10	3.25	5.79	0.42	0.57	0.28	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	95.87	3.50	2.55	0.96	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	154.79	5.75	2.87	1.99	1.99	0.22	0.88	0.44	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	122.10	2.65	6.83	0.00	1.14	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	126.43	7.10	6.25	0.57	0.57	0.57	0.28	0.00	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	133.96	4.92	4.92	3.20	1.47	0.74	1.47	0.74	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	94.49	0.65	3.26	1.30	0.00	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	125.26	3.23	3.82	1.18	1.76	0.59	0.88	0.88	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	97.74	3.75	1.73	1.44	1.44	0.29	0.00	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	248.93	4.95	11.95	1.24	0.82	0.00	0.00	0.82	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	95.59	3.87	4.47	0.89	0.30	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	67.80	0.00	0.00	3.77	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	110.50	3.56	0.00	0.00	1.78	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	231.64	9.20	6.90	4.93	2.96	0.66	2.63	0.66	2.63
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	128.34	9.47	1.05	4.21	3.16	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	135.02	2.97	3.36	0.99	0.40	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	130.39	1.86	0.93	0.00	0.93	0.00	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	200.91	10.14	7.14	1.88	1.88	0.00	0.75	1.13	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	95.08	1.86	3.20	1.07	0.53	0.27	0.27	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	213.42	3.39	4.07	0.90	1.24	0.57	0.23	0.11	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	120.09	11.05	2.95	0.74	0.00	0.74	0.00	0.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	182.48	11.73	4.03	6.96	4.40	0.00	0.00	0.73	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	192.89	31.11	1.56	14.00	12.44	0.00	3.11	1.56	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	195.60	2.14	6.95	1.07	0.53	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	88.87	3.86	0.00	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	130.28	11.11	6.06	8.08	1.01	0.00	3.03	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	127.76	6.75	2.53	2.95	2.11	0.00	0.84	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	215.19	1.36	4.09	1.36	0.00	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	109.36	0.00	2.54	0.64	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	109.33	0.81	3.24	0.00	1.62	1.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	101.20	6.04	6.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	1090.64	0.00	11.42	0.00	11.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	1210.37	6.52	13.05	3.26	0.00	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	465.74	4.75	9.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	401.57	0.00	0.00	12.55	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	361.50	10.77	8.83	4.09	2.59	4.52	1.94	1.08	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	296.32	18.29	12.02	4.70	2.09	3.14	2.09	1.05	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	325.07	2.00	4.67	1.33	0.00	1.33	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	177.38	1.25	3.34	0.00	0.00	3.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	322.29	6.46	6.27	2.47	1.14	7.42	3.23	0.76	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	855.38	9.58	15.96	9.58	1.60	22.34	0.00	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	193.10	0.68	2.72	0.68	0.00	2.72	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1512.38	86.37	18.38	20.21	14.70	27.56	5.51	1.84	12.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	156.95	0.42	1.67	0.42	0.42	0.84	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	191.30	0.70	4.18	0.93	0.46	2.56	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	263.74	0.00	2.97	0.81	0.54	1.35	0.27	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	261.95	5.26	5.05	2.31	1.05	4.20	1.26	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	5634.17	445.39	111.35	89.08	89.08	144.75	22.27	33.40	89.08
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	194.08	1.49	6.45	1.49	0.50	0.99	0.50	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	119.09	2.17	3.79	1.89	0.81	2.17	0.54	0.00	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	165.25	0.68	2.49	0.45	0.23	1.13	0.68	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	131.29	0.16	2.29	0.16	0.00	0.82	0.65	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	254.06	11.12	6.38	2.55	2.55	2.00	1.46	2.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	188.30	1.59	8.49	1.06	1.06	1.59	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	208.91	0.00	2.40	0.60	0.00	1.20	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	274.03	5.58	7.55	3.61	0.66	2.63	1.97	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	131.89	0.16	2.44	0.16	0.00	1.14	0.49	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	417.32	14.46	11.29	6.00	3.35	5.12	1.06	3.00	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	203.94	1.41	4.22	0.70	0.00	2.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	141.13	1.84	2.76	0.46	0.46	0.92	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	171.60	1.29	3.86	0.64	0.00	0.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	272.81	7.59	8.97	4.83	3.45	4.83	2.41	0.34	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2187.11	68.27	60.68	37.93	30.34	73.32	15.17	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	281.38	4.68	7.13	1.56	1.56	3.12	0.89	1.11	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	159.20	2.12	3.81	1.69	0.42	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	150.24	2.85	2.85	0.47	0.24	3.32	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	164.40	0.86	3.86	0.00	0.00	1.29	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	7556.23	207.64	153.47	117.36	72.22	207.64	63.19	45.14	54.17
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	151.95	0.33	3.00	0.33	0.00	0.67	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	270.97	3.16	6.76	1.80	0.45	2.25	0.90	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	174.20	0.40	2.38	0.79	0.79	3.57	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	234.02	0.93	4.64	0.93	0.00	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	141.13	1.89	1.14	1.14	0.00	2.27	1.14	0.38	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	189.67	0.65	4.89	0.98	0.33	2.61	0.65	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	137.27	0.44	1.31	0.00	0.00	1.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	371.78	8.59	9.05	4.07	2.26	3.17	0.45	1.36	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	149.92	0.88	9.70	1.76	0.00	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	206.10	1.99	7.98	0.00	0.66	1.99	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	171.63	1.49	3.97	0.99	0.50	1.49	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	156.58	0.38	2.68	0.00	0.00	2.68	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	175.12	5.14	4.54	1.21	0.30	2.12	0.00	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	284.24	7.96	8.84	1.99	0.88	2.43	0.44	2.21	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	168.06	0.00	3.39	0.68	1.36	0.00	0.00	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1839.43	66.42	76.64	56.20	25.55	40.88	5.11	0.00	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	164.61	0.61	2.44	0.00	0.00	2.44	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	127.78	0.63	4.72	0.31	0.00	1.26	1.26	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	191.58	0.61	1.51	0.00	0.61	0.61	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	155.85	1.58	3.96	0.79	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	354.83	5.67	12.47	4.53	1.13	6.80	3.40	0.00	5.67
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1825.90	96.10	60.69	25.29	45.52	45.52	5.06	0.00	20.23
Myoblast, donor1	11241-116D8	406.85	13.42	6.46	3.35	1.86	6.71	1.24	0.75	1.86
Myoblast, donor2	11322-117D8	379.17	30.11	13.43	7.10	5.95	7.29	2.30	2.49	2.11
Myoblast, donor3	11398-118D3	464.13	8.07	12.28	2.69	1.51	7.74	0.34	1.01	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	726.75	48.01	14.45	14.89	11.53	6.13	5.84	5.98	6.71
Natural Killer Cells, donor1	11230-116C6	862.89	35.06	29.21	5.54	5.23	1.85	3.69	4.92	4.61
Natural Killer Cells, donor2	11311-117C6	465.30	51.57	15.98	17.79	9.05	0.90	7.84	5.13	5.73
Natural Killer Cells, donor3	11387-118C1	512.77	49.51	22.45	13.99	9.20	1.29	4.42	6.07	6.07
Neural stem cells, donor1	11275-116H6	1257.95	21.41	33.39	10.16	2.54	15.24	2.90	1.45	4.72
Neural stem cells, donor2	11352-117H2	1555.92	7.70	42.36	3.85	0.00	19.26	0.00	1.93	3.85
Neurons, donor1	11494-119E9	587.16	17.07	17.07	1.14	3.41	1.14	1.14	5.69	2.28
Neurons, donor2	11574-120E8	437.24	14.75	9.47	1.98	1.32	2.86	1.54	0.44	0.66
Neurons, donor3	11655-122E8	477.68	18.09	10.69	9.04	6.58	8.22	3.29	7.40	1.64
Neutrophils, donor1	11233-116C9	109.50	7.42	1.86	0.00	0.93	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	69.57	11.60	2.90	5.80	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	140.49	1.83	3.05	0.61	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	486.93	19.35	7.72	4.16	3.21	6.06	1.07	2.26	1.78
Nucleus Pulposus Cell, donor2	11409-118E5	179.41	7.16	2.60	2.60	2.28	1.30	0.33	0.65	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	186.31	1.00	6.02	2.21	1.20	4.01	1.60	0.60	1.20
Olfactory epithelial cells, donor1	11933-125I7	214.32	11.84	8.53	3.85	2.34	2.20	1.51	2.06	1.10
Olfactory epithelial cells, donor2	11934-125I8	303.10	26.49	6.80	7.53	6.80	5.65	4.92	3.76	2.75
Olfactory epithelial cells, donor3	11935-125I9	232.34	15.32	3.63	5.11	2.16	3.86	1.36	2.16	1.25
Olfactory epithelial cells, donor4	11936-126A1	256.64	13.83	6.33	4.09	3.12	4.09	1.66	1.66	1.56
Oligodendrocyte - precursors, donor1	11496-119F2	521.78	10.83	5.42	7.22	4.21	0.60	0.00	2.41	1.81
Osteoblast - differentiated, donor1	11276-116H7	178.88	0.85	5.53	0.64	0.43	1.91	0.21	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	81.16	2.29	0.00	1.14	0.00	0.00	3.43	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	132.83	1.86	3.10	1.24	1.24	0.62	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	144.23	1.56	2.35	0.20	0.20	1.17	0.20	0.20	0.00
Osteoblast, donor2	11354-117H4	703.02	15.45	11.94	5.62	3.51	9.13	2.11	1.40	2.11
Osteoblast, donor3	11426-118G4	200.48	6.04	4.27	1.24	1.60	2.31	1.07	0.36	0.71
Pancreatic stromal cells, donor1	11249-116E7	554.02	23.84	9.27	4.38	3.03	8.34	2.44	2.19	1.77
Pericytes, donor1	11491-119E6	56.52	0.11	1.56	0.67	0.11	0.45	0.11	0.33	0.00
Pericytes, donor2	11571-120E5	39.61	0.23	1.13	0.23	0.45	0.23	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	89.92	4.68	1.02	0.81	0.61	1.02	0.41	0.41	0.20
Perineurial Cells, donor1	11499-119F5	581.16	13.22	8.14	4.18	4.18	6.22	2.26	1.81	1.81
Perineurial Cells, donor2	11579-120F4	440.09	6.81	6.16	1.38	1.75	2.85	0.28	0.92	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	738.84	12.75	33.79	6.69	1.27	3.82	1.91	1.91	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	325.67	19.59	13.71	3.43	4.16	1.47	0.98	2.45	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	398.47	16.31	16.44	3.49	2.72	1.04	1.16	2.33	1.55
Placental Epithelial Cells, donor1	11278-116H9	279.11	2.15	4.07	1.43	0.96	0.72	0.96	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	214.01	6.65	5.54	1.11	1.11	1.11	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	192.79	10.60	4.71	1.18	1.96	0.20	0.98	0.98	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	73.42	2.85	0.95	0.63	0.00	2.22	0.00	0.00	1.27
Preadipocyte - breast, donor1	11467-119B9	231.30	3.38	6.75	1.13	0.56	4.13	0.75	0.75	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	532.42	5.74	10.57	2.48	1.96	5.87	0.78	0.26	1.04
Preadipocyte - breast, donor2	11328-117E5	179.22	12.83	5.40	2.93	2.93	3.38	1.80	1.58	0.23
Preadipocyte - omental, donor1	11468-119C1	274.39	6.93	8.52	2.77	0.64	4.05	0.64	0.53	0.96
Preadipocyte - omental, donor2	11329-117E6	279.78	6.11	6.98	3.49	2.18	1.75	0.87	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	225.76	12.03	4.58	4.44	2.29	2.72	1.29	1.15	2.15
Preadipocyte - perirenal, donor1	11469-119C2	101.38	0.00	2.95	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	111.79	0.31	2.15	0.00	0.00	1.23	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	698.92	54.01	8.85	16.47	9.92	5.14	5.14	6.91	7.44
Preadipocyte - subcutaneous, donor3	11428-118G6	332.57	17.03	4.60	3.92	1.87	3.07	1.53	1.70	2.38
Preadipocyte - visceral, donor1	11280-116I2	857.23	18.91	12.39	7.17	2.05	11.46	2.14	2.24	2.79
Preadipocyte - visceral, donor2	11357-117H7	442.69	25.77	6.44	6.44	4.14	5.52	1.84	5.06	1.38
Preadipocyte - visceral, donor3	11429-118G7	389.85	7.42	8.36	5.43	5.54	5.64	1.99	1.25	1.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	830.44	45.71	8.60	10.56	6.49	1.21	4.68	4.68	4.53
Prostate Epithelial Cells, donor2	11331-117E8	207.05	16.79	5.15	3.25	2.57	1.49	0.41	2.03	1.62
Prostate Epithelial Cells, donor3	11404-118D9	340.05	40.97	4.04	14.64	6.74	0.55	4.96	4.16	4.65
Prostate Stromal Cells, donor1	11254-116F3	584.54	18.57	7.40	5.13	3.19	2.62	1.59	2.28	2.28
Prostate Stromal Cells, donor2	11332-117E9	483.03	60.42	8.96	15.24	12.73	4.30	7.71	5.92	5.38
Prostate Stromal Cells, donor3	11405-118E1	209.18	20.02	5.63	2.71	2.61	2.19	1.36	1.56	1.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	140.52	1.09	0.73	1.09	0.00	1.46	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	431.95	18.64	4.30	4.23	2.01	1.66	0.76	1.32	1.39
Renal Epithelial Cells, donor1	11517-119H5	85.21	0.51	0.51	1.01	0.51	0.00	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	111.68	3.56	0.71	3.56	0.71	0.71	0.00	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	545.10	22.66	4.66	5.72	3.07	2.86	1.27	1.38	1.80
Renal Glomerular Endothelial Cells, donor1	11514-119H2	50.38	0.00	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	133.69	0.67	1.35	1.35	0.40	0.94	0.13	0.54	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	493.97	41.07	6.88	16.87	9.77	4.66	5.99	5.77	3.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	79.19	0.00	0.67	0.00	0.00	1.33	0.67	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	145.26	2.42	1.98	1.32	0.00	0.88	0.66	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	79.00	5.64	1.88	1.25	1.25	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	42.17	1.39	0.83	0.28	0.83	0.00	0.00	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	325.33	4.83	3.22	2.42	0.81	2.42	0.00	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	110.91	3.80	2.53	1.69	0.42	0.42	0.84	0.00	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	134.03	7.14	0.77	1.16	1.54	0.96	0.19	0.77	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	526.60	16.85	7.00	4.67	3.37	1.56	3.37	0.78	3.11
Retinal Pigment Epithelial Cells, donor1	11528-119I7	229.10	3.41	3.41	1.99	0.28	2.27	1.14	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	148.19	9.26	0.00	4.12	2.06	1.03	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	676.45	12.04	11.54	4.01	1.00	5.02	1.00	2.51	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	455.03	13.63	7.88	4.68	2.41	1.60	1.60	1.47	1.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	507.45	3.57	4.47	5.36	0.89	4.47	0.89	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1637.90	118.88	15.96	31.37	18.71	16.51	12.11	14.86	8.81
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	2297.02	71.93	20.88	15.08	9.86	31.90	8.70	15.66	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	1500.62	6.76	22.10	17.81	7.28	14.69	2.21	2.21	4.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	823.34	72.69	12.12	18.27	14.00	5.96	9.04	7.75	6.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	1208.86	25.21	13.16	6.13	3.35	7.47	2.45	2.79	4.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	1481.70	49.37	25.06	27.79	21.96	13.15	11.41	6.57	11.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	897.16	77.15	13.17	22.49	13.52	7.46	8.97	8.16	6.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	1176.69	99.85	15.02	28.66	15.95	7.86	12.71	9.48	10.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	827.61	10.13	12.32	14.38	10.54	8.49	2.88	2.88	4.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	1066.93	112.85	15.88	33.13	16.03	6.35	6.96	8.02	9.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	791.13	7.53	6.09	1.79	0.72	4.48	0.54	1.97	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	761.75	14.78	14.20	15.92	11.48	7.89	4.02	3.16	5.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	874.29	68.04	10.62	14.27	13.74	6.12	6.55	7.73	6.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	760.95	42.93	10.84	8.85	7.97	5.31	3.54	3.76	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	926.63	5.93	15.29	15.10	11.66	7.84	1.34	1.72	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	874.24	46.49	11.83	9.97	9.04	6.15	5.50	3.35	5.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	1734.38	60.13	20.29	19.17	5.83	12.78	6.58	6.39	8.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	918.46	8.49	15.00	13.67	8.36	5.71	3.72	3.32	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	1034.15	105.71	16.06	20.25	21.42	8.18	9.25	11.10	8.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	953.84	58.43	12.99	11.84	10.31	4.96	7.07	5.16	5.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	806.61	8.97	14.31	11.96	9.50	7.58	2.88	2.24	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	984.99	102.03	15.70	26.63	18.50	5.61	5.89	9.81	7.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	936.18	59.47	12.48	14.70	11.79	7.18	8.37	9.40	5.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	744.64	6.56	9.85	8.02	5.29	5.47	2.55	1.64	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	829.36	85.60	13.98	20.11	14.35	5.76	9.32	9.44	10.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	793.29	56.55	11.15	9.94	8.73	7.52	5.64	6.18	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	983.12	7.08	16.28	19.11	8.49	8.49	3.54	1.89	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	943.06	90.67	15.28	26.39	14.68	6.94	7.54	8.93	8.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	913.17	69.22	12.86	13.80	10.06	4.91	4.21	4.68	5.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	827.14	11.61	14.31	14.31	9.12	4.15	3.94	3.53	4.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	1059.60	74.55	23.89	22.56	12.61	8.18	8.18	13.49	7.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	862.48	45.33	12.12	10.44	9.40	5.64	3.34	4.60	5.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	958.92	14.67	18.44	18.17	12.11	9.29	5.25	4.71	4.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	1010.70	43.43	16.52	7.32	9.71	10.39	2.90	6.64	4.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	950.28	66.13	11.76	18.12	11.18	6.56	5.40	6.94	5.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1026.12	11.86	16.85	22.52	13.41	10.32	3.95	2.24	5.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	833.30	45.40	16.32	8.50	8.78	6.58	4.39	3.84	6.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	1024.42	71.25	18.39	17.89	11.98	7.22	6.90	8.87	8.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	739.16	8.01	12.27	11.93	9.37	6.99	3.58	3.24	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	1002.86	90.70	13.91	15.39	16.72	8.88	8.73	12.28	10.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	842.30	26.66	6.93	6.40	6.66	5.33	1.87	3.73	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	729.36	9.13	10.92	12.17	8.85	6.91	4.98	1.94	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	604.07	40.72	8.33	7.38	8.10	4.05	3.81	3.57	5.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	1089.94	39.91	11.29	5.44	4.84	12.50	2.62	2.42	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	562.31	7.06	10.83	12.05	5.37	6.87	2.92	2.45	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	899.61	96.07	14.67	22.71	15.02	9.78	11.53	8.73	10.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	760.07	25.69	6.35	9.67	5.44	9.07	2.72	2.42	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	580.72	5.51	11.63	9.18	4.41	5.39	2.69	1.59	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1389.30	17.76	17.32	4.08	3.49	13.39	2.77	1.60	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	591.39	17.04	6.69	3.04	4.87	4.87	3.65	3.04	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	556.99	5.12	9.04	6.03	4.52	4.22	2.11	1.81	2.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	588.32	28.73	10.40	6.33	4.30	4.52	2.49	3.62	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	559.84	33.55	9.59	4.79	5.69	3.89	4.19	2.40	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	711.28	2.60	13.46	6.97	2.72	8.15	1.53	1.53	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	479.18	30.10	5.55	2.56	2.77	2.35	9.82	2.35	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	533.07	13.22	5.41	2.40	1.80	4.81	3.61	0.00	2.40
Schwann Cells, donor1	11498-119F4	96.48	0.56	1.32	1.50	0.38	1.32	0.75	0.56	0.75
Schwann Cells, donor2	11578-120F3	381.07	23.82	3.40	0.00	6.80	3.40	0.00	3.40	10.21
Schwann Cells, donor3	11659-122F3	258.95	21.91	6.35	5.92	4.82	2.85	2.63	1.31	1.53
Sebocyte, donor1	11220-116B5	954.21	9.86	11.50	2.19	0.55	4.93	0.55	1.10	1.10
Sebocyte, donor2	11301-117B5	575.82	24.82	5.51	6.89	5.51	1.38	0.92	5.51	1.38
Sebocyte, donor3	11378-118B1	171.49	4.53	1.44	2.06	1.65	0.21	0.82	0.21	1.24
Sertoli Cells, donor1	11255-116F4	362.79	8.28	11.60	6.63	6.63	6.63	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	279.61	25.42	19.77	16.95	2.82	2.82	0.00	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	583.56	13.11	11.53	3.96	1.67	8.80	1.41	1.06	1.58
Skeletal Muscle Cells, donor2	11358-117H8	41.20	1.45	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	175.57	1.67	2.51	1.67	0.00	1.67	1.67	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	568.21	8.80	7.54	4.71	4.71	3.30	1.41	1.10	1.26
Skeletal Muscle Cells, donor5	11455-119A6	509.26	6.99	7.43	4.01	4.61	3.12	1.93	1.78	1.93
Skeletal Muscle Cells, donor6	11459-119B1	680.86	13.54	7.08	4.00	7.39	2.77	2.77	1.54	2.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	647.17	21.17	9.45	4.41	3.15	4.54	2.14	2.02	3.02
Skeletal Muscle Satellite Cells, donor2	11321-117D7	399.67	27.54	4.71	7.85	4.71	2.57	2.57	2.85	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	694.87	29.76	7.14	6.45	5.46	3.57	4.17	3.87	2.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	569.54	17.61	12.81	4.21	2.02	6.49	2.11	1.35	1.52
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	139.69	0.72	1.45	2.90	1.45	2.17	1.45	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	77.19	0.69	2.34	1.93	0.41	0.28	0.28	0.55	0.28
Skin - palm, donor1	10286-104F7	453.95	21.49	13.43	29.55	21.49	13.43	13.43	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	169.67	4.04	2.16	2.59	1.30	0.86	0.43	0.58	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	455.57	0.82	3.27	3.27	0.00	4.09	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	218.63	2.21	2.21	1.04	1.43	0.65	0.39	0.91	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	438.99	13.76	10.43	3.48	1.67	2.22	0.70	2.09	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	370.77	21.66	4.22	2.81	3.66	2.81	2.11	2.67	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	840.07	9.94	8.46	5.29	3.59	2.54	1.48	1.27	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	321.09	18.36	4.65	5.77	4.12	0.97	2.47	2.25	1.42
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	178.67	2.47	4.32	3.39	2.16	6.79	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	386.63	4.45	15.79	5.34	2.67	5.56	2.45	1.56	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	171.65	1.18	2.94	0.00	0.00	4.11	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	172.37	3.54	4.86	0.44	0.44	1.77	1.10	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	163.42	1.58	1.58	0.39	0.39	1.97	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	205.50	1.55	6.95	0.00	0.77	1.55	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	300.23	19.01	6.00	4.00	2.00	1.00	1.00	2.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	186.31	1.33	3.59	0.53	0.13	3.19	0.53	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	285.71	29.48	11.08	4.43	7.54	6.21	4.43	1.11	3.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	277.95	2.30	7.04	2.94	1.79	5.38	0.38	0.51	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	320.38	4.56	3.91	1.30	0.33	1.63	0.33	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	374.47	4.13	5.91	1.77	1.48	5.02	0.89	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	167.99	5.13	2.28	0.71	0.85	1.14	1.00	0.28	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	63.93	1.63	0.49	0.16	0.33	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	249.94	14.00	6.09	9.74	5.18	3.96	0.91	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	151.79	1.52	3.03	0.76	0.25	1.52	0.76	0.76	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	83.92	0.48	2.38	0.00	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	329.90	5.46	2.51	1.03	1.18	2.51	0.44	0.44	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	287.99	12.05	4.30	4.09	2.15	0.86	0.65	1.29	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	334.40	12.39	4.93	2.94	2.83	2.20	0.94	1.47	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	187.63	1.70	2.63	1.08	0.00	1.55	0.00	0.31	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	114.25	1.08	3.23	0.00	0.00	2.16	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	170.05	0.60	1.79	1.49	0.30	1.49	0.00	1.20	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	124.61	2.05	1.02	0.00	0.68	1.02	0.00	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	428.53	20.34	6.36	4.55	3.61	2.59	1.81	1.81	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	501.29	15.80	13.08	7.45	1.51	12.18	1.71	1.71	3.32
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	243.94	21.62	7.96	6.60	2.50	2.96	2.96	1.82	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	92.99	0.60	2.42	0.60	1.21	0.60	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1534.18	36.82	8.74	14.31	7.68	6.62	6.36	3.97	6.36
Smooth Muscle Cells - Prostate, donor1	11257-116F6	382.57	2.13	8.79	3.86	2.80	6.26	0.93	0.53	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	292.76	29.18	7.26	7.64	4.51	3.88	2.13	2.00	3.76
Smooth Muscle Cells - Prostate, donor3	11465-119B7	177.31	2.03	5.58	1.01	1.27	1.78	0.25	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	356.28	4.52	4.52	1.81	1.06	4.98	0.45	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	74.27	2.25	3.00	2.25	0.75	2.25	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	127.93	0.00	2.58	0.00	0.00	0.00	0.00	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	148.82	0.47	2.79	0.47	0.00	2.33	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	232.25	9.59	7.07	1.51	0.50	7.07	0.50	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	123.79	1.88	3.13	0.63	0.31	3.13	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	70.21	1.18	2.36	0.59	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1083.90	7.00	11.16	2.75	1.58	11.91	0.75	0.58	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	237.32	8.88	2.34	2.34	1.40	2.80	0.93	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	134.56	1.15	2.88	0.43	0.29	2.16	0.14	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	177.96	5.10	2.55	1.78	1.02	1.78	1.27	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	132.00	1.50	2.26	0.56	0.38	1.69	0.75	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	708.22	14.53	9.22	4.05	3.63	6.71	1.40	1.68	2.24
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	368.75	4.86	5.36	1.93	1.42	3.27	0.50	0.42	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	59.05	1.43	1.43	0.95	0.00	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	132.12	1.47	2.94	0.49	0.00	0.98	0.00	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	379.59	2.43	9.06	3.76	2.21	6.41	0.88	0.44	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	277.66	9.66	5.56	2.05	1.17	2.93	1.46	0.88	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	141.69	7.39	3.69	3.69	0.97	0.78	0.78	0.58	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	165.02	7.40	6.61	2.91	1.32	1.59	1.32	0.79	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	296.07	11.53	8.55	4.09	1.49	5.58	1.86	2.23	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	234.29	10.78	7.91	4.31	2.16	3.59	1.08	0.72	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	168.64	5.39	5.11	1.42	0.85	4.83	0.00	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	401.35	14.57	5.91	7.88	3.15	4.73	0.39	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	204.94	10.41	5.33	3.81	2.54	6.09	0.76	1.02	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	140.96	4.39	2.80	2.00	0.40	2.00	0.40	0.00	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	129.58	4.18	2.93	1.25	0.42	0.84	0.00	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	147.13	5.50	2.75	0.00	0.46	0.92	0.00	0.46	0.92
Synoviocyte, donor1	11291-117A4	337.48	9.93	4.88	2.19	0.34	2.86	0.84	1.18	1.35
Synoviocyte, donor2	11368-117I9	185.06	12.40	6.87	2.35	2.85	3.02	1.17	0.34	0.84
Synoviocyte, donor3	11440-118H9	147.23	4.92	5.81	2.68	1.79	2.68	0.89	0.89	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	242.99	1.79	2.86	1.07	0.00	0.36	0.36	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	132.80	0.00	0.00	0.00	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	124.34	3.24	1.85	0.46	0.69	0.46	0.23	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	346.52	4.44	2.65	2.29	0.14	1.65	0.36	0.43	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	88.91	1.55	1.16	0.00	1.16	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	83.04	1.15	1.15	0.57	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	470.44	15.38	8.86	3.57	2.95	1.60	1.48	1.35	0.98
Urethra, donor2	10319-105A4	377.67	28.77	8.99	23.38	14.39	0.00	7.19	0.00	1.80
Urothelial Cells, donor1	11520-119H8	64.29	0.80	2.13	0.27	0.00	0.00	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	60.08	2.40	0.80	0.00	0.80	0.40	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	43.09	1.38	0.69	1.15	0.23	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	294.44	8.69	3.34	0.89	3.12	1.34	1.34	0.45	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	380.83	0.89	12.46	0.89	4.45	0.89	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	318.80	2.86	10.01	0.00	1.43	0.00	0.00	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	160.86	4.11	5.48	0.68	2.05	0.00	1.37	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	372.23	5.85	7.58	1.72	1.03	1.03	1.03	0.34	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	332.93	5.23	9.30	2.32	0.58	1.16	0.58	0.00	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	278.01	1.04	10.41	2.08	1.04	0.00	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	340.50	1.84	15.60	2.75	0.92	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	164.32	11.87	5.48	0.00	1.83	0.00	1.83	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	932.24	47.74	12.46	14.80	9.13	4.93	7.15	3.70	5.30
Wilms' tumor cell line:HFWT	10597-108E3	501.62	24.64	8.80	14.08	7.92	3.52	0.88	0.88	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	806.39	42.18	6.98	11.17	8.10	6.14	6.70	7.54	6.14
achilles tendon, donor2	10292-104G4	175.65	22.73	6.20	8.27	2.07	2.07	6.20	6.20	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	2791.00	204.22	20.91	57.37	36.20	9.18	19.63	15.55	30.59
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1955.14	51.77	14.39	19.04	11.38	9.98	7.20	4.64	9.98
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1707.73	53.30	16.98	18.99	8.19	9.14	6.05	4.15	9.73
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1679.49	108.85	18.23	37.28	16.87	9.25	10.88	8.16	15.24
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1885.23	170.62	20.24	57.62	34.57	6.75	22.49	23.61	21.36
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	661.09	18.19	7.40	2.75	1.48	3.81	2.33	0.42	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	1080.14	63.97	11.71	29.94	11.71	6.81	8.98	4.08	13.61
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	557.85	45.39	3.08	18.95	9.25	1.32	2.64	1.76	5.73
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	1000.89	62.07	10.62	38.79	15.52	7.35	9.39	6.53	11.84
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	860.86	54.75	13.59	23.30	10.87	11.26	9.71	6.99	5.44
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1872.57	155.48	16.74	66.79	28.34	2.94	18.95	23.00	15.82
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	940.02	15.60	15.60	11.70	15.60	15.60	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1141.69	88.07	16.27	42.76	18.36	8.83	13.25	11.39	13.48
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2219.82	148.61	27.96	62.91	29.00	5.18	20.45	20.71	18.64
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1860.13	200.48	16.07	79.20	35.07	8.18	20.75	25.72	20.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	883.51	32.07	5.58	14.41	9.30	4.18	4.65	1.86	2.79
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	405.08	16.45	6.58	15.63	3.29	2.06	2.47	2.88	4.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	471.17	6.14	4.60	5.53	8.59	2.76	0.92	2.15	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1255.38	60.17	11.09	18.35	8.11	4.69	6.40	4.27	5.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1206.50	30.03	12.44	7.89	6.07	6.67	2.43	2.43	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1458.68	33.46	15.16	7.94	6.02	5.78	3.13	3.13	7.70
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1344.45	101.12	10.69	37.20	14.70	5.57	11.81	14.26	15.15
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1938.24	46.03	15.01	17.01	12.01	4.34	7.67	9.01	6.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	2196.40	33.45	18.58	24.16	11.15	29.73	3.72	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1237.71	64.03	11.30	24.11	12.43	3.77	9.04	7.53	8.29
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1596.25	48.41	22.68	15.26	12.65	23.55	3.49	6.98	4.80
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1612.04	15.00	24.37	16.87	5.62	39.36	1.87	3.75	3.75
adenocarcinoma cell line:IM95m	10796-110I4	436.62	13.66	10.13	5.65	3.53	7.77	2.35	1.65	2.83
adipose tissue, adult, pool1	10010-101C1	429.37	10.39	8.38	2.79	2.02	4.50	0.47	1.55	0.78
adipose, donor1	10184-103D4	789.89	74.47	12.31	25.80	18.77	2.35	11.14	4.69	14.07
adipose, donor2	10185-103D5	163.83	8.92	0.81	3.65	1.22	0.81	1.22	1.22	0.81
adipose, donor3	10186-103D6	337.64	30.22	3.00	8.44	6.53	1.36	1.91	3.54	4.63
adipose, donor4	10187-103D7	579.86	98.81	7.80	30.34	15.60	1.73	9.53	6.93	11.27
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	836.13	22.09	17.68	7.58	3.63	13.57	5.37	2.68	2.84
adrenal gland, adult, pool1	10081-102A9	152.78	3.64	3.64	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	454.78	16.54	3.60	4.27	2.27	1.33	1.33	1.47	2.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	669.22	29.66	8.58	13.58	4.64	6.43	8.93	2.86	6.07
amniotic membrane cells, donor1	12235-129G3	366.55	8.81	5.80	3.01	3.25	1.62	1.39	1.39	0.70
amniotic membrane cells, donor2	12236-129G4	295.16	7.78	5.75	0.34	1.69	1.35	0.34	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	362.07	6.19	8.25	5.30	3.83	2.36	0.88	1.18	2.95
amygdala - adult, donor10196	10167-103B5	429.26	13.04	10.67	7.11	5.93	5.93	5.93	5.93	3.56
amygdala, adult, donor10252	10151-102I7	422.16	38.93	9.12	14.60	8.72	5.88	4.46	5.27	5.07
amygdala, newborn, donor10223	10360-105E9	170.42	6.13	2.26	1.61	0.32	5.16	1.61	0.32	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	462.84	14.52	6.24	3.44	2.67	2.55	2.16	1.27	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1038.92	56.70	10.37	20.96	11.03	3.53	6.62	5.96	6.40
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	694.13	29.73	13.03	12.36	3.67	11.36	5.01	2.00	3.01
aorta, adult, pool1	10052-101G7	264.58	16.67	3.73	4.31	5.69	1.57	3.14	2.94	2.16
appendix, adult	10189-103D9	508.82	19.41	9.70	3.88	5.82	1.55	1.55	1.94	3.49
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	708.51	40.24	12.73	14.45	13.41	6.53	5.50	4.47	2.41
artery, adult	10190-103E1	270.38	20.38	8.15	5.43	5.43	0.00	2.72	5.43	0.00
astrocytoma cell line:TM-31	10425-106D2	625.25	17.82	13.18	5.94	2.17	6.95	1.16	1.16	2.61
b cell line:RPMI1788	10427-106D4	995.26	36.43	12.19	9.81	6.54	4.76	4.61	3.87	5.35
basal cell carcinoma cell line:TE 354.T	10702-109G9	264.41	11.38	6.66	1.66	1.39	4.72	0.55	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	1079.74	31.75	9.82	8.53	6.55	5.16	2.08	2.58	4.56
bile duct carcinoma cell line:TFK-1	10496-107C1	954.73	31.63	8.87	9.37	4.52	6.19	3.85	4.02	2.18
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	521.21	22.93	8.39	7.27	5.59	1.68	2.24	2.80	1.68
bladder, adult, pool1	10011-101C2	491.71	14.23	8.04	4.45	2.82	1.96	1.20	1.09	1.52
blood, adult, pool1	10053-101G8	132.88	8.86	2.21	0.00	2.21	0.00	2.21	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	465.85	6.85	11.13	2.57	2.57	5.99	0.86	0.86	0.86
bone marrow, adult	10192-103E3	424.47	43.19	12.15	24.29	6.75	3.37	7.42	4.05	3.37
brain, adult, donor1	10084-102B3	141.46	7.18	10.25	2.05	1.03	2.05	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	455.79	20.27	13.59	6.57	4.45	5.01	2.23	1.78	2.56
brain, fetal, pool1	10085-102B4	213.71	5.34	5.34	0.00	0.00	5.34	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	784.29	43.28	13.21	8.92	9.91	9.25	3.30	3.63	3.30
breast carcinoma cell line:MDA-MB-453	10419-106C5	1038.90	18.35	16.48	4.74	2.75	3.25	1.87	2.62	2.50
breast, adult, donor1	10080-102A8	204.56	1.89	1.26	0.63	2.53	0.00	1.26	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	561.51	53.74	28.20	18.93	9.40	21.47	6.48	4.83	5.21
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	924.57	52.26	27.83	17.93	8.66	25.97	11.75	5.57	7.73
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	748.21	23.48	14.04	7.14	2.99	5.30	2.76	3.45	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	764.27	56.89	11.86	18.40	13.07	17.43	8.96	5.33	9.20
carcinoid cell line:NCI-H1770	10703-109H1	557.15	16.46	12.22	8.93	2.82	6.11	1.88	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	576.65	16.52	9.95	5.25	4.70	3.94	2.30	1.86	2.30
carcinoid cell line:SK-PN-DW	10719-109I8	946.88	47.53	11.73	22.82	8.24	6.02	9.19	7.29	7.61
carcinosarcoma cell line:JHUCS-1	10642-109A3	987.25	84.64	22.36	23.16	19.70	11.98	10.38	12.78	6.12
caudate nucleus - adult, donor10196	10177-103C6	592.93	5.76	12.66	10.36	3.45	6.91	2.30	2.30	6.91
caudate nucleus, adult, donor10252	10164-103B2	391.21	40.16	10.21	15.39	10.04	5.19	4.52	4.35	6.36
caudate nucleus, adult, donor10258	10379-105H1	323.99	14.52	4.58	7.64	6.88	3.82	2.29	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	266.98	8.06	5.13	2.56	0.73	7.69	1.10	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	917.68	17.48	11.65	14.57	5.83	5.83	11.65	5.83	2.91
cerebellum, adult, donor10252	10166-103B4	850.84	74.09	17.29	19.43	13.66	1.49	6.62	9.18	6.62
cerebellum, adult, pool1	10083-102B2	279.41	19.66	7.59	5.17	4.83	2.07	5.52	1.72	1.38
cerebellum, newborn, donor10223	10357-105E6	381.93	24.08	5.81	7.47	0.00	0.00	3.32	1.66	1.66
cerebral meninges, adult	10188-103D8	330.81	15.38	7.31	7.06	4.79	4.03	1.01	1.51	3.53
cerebrospinal fluid, donor2	10294-104G6	209.76	16.08	5.12	12.43	5.85	2.92	2.92	2.92	2.92
cervical cancer cell line:D98-AH2	10552-107I3	762.48	13.80	8.63	4.60	1.73	5.46	1.87	1.15	3.02
cervical cancer cell line:ME-180	10553-107I4	628.56	11.93	8.78	2.98	1.99	2.32	2.49	0.99	2.15
cervix, adult, pool1	10013-101C4	581.12	18.79	12.91	4.62	3.57	3.67	1.47	1.89	2.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	326.47	4.60	7.38	1.67	0.98	2.23	0.28	0.28	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	267.78	5.23	10.45	1.31	0.00	5.23	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1255.06	48.84	15.53	12.30	5.10	13.92	5.22	3.36	6.46
choriocarcinoma cell line:SCH	10785-110H2	450.96	31.67	6.28	12.32	5.42	5.79	3.08	2.22	3.33
choriocarcinoma cell line:T3M-3	10618-108G6	1218.86	19.92	11.62	8.30	5.46	14.47	4.27	3.08	1.66
chorionic membrane cells, donor1	12238-129G6	298.60	10.26	4.27	1.71	3.42	1.42	0.57	0.28	1.14
chorionic membrane cells, donor2	12239-129G7	334.09	7.46	7.36	2.88	1.89	2.19	0.80	0.20	0.99
chorionic membrane cells, donor3	12240-129G8	385.19	10.99	4.40	7.14	9.89	4.40	1.65	2.75	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	659.40	40.39	11.11	4.04	11.11	10.10	5.05	5.05	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	882.31	39.76	9.22	14.02	5.38	3.46	3.46	3.27	6.53
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	835.66	17.11	10.35	4.65	4.22	6.55	1.90	2.53	2.11
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	850.27	33.90	6.68	9.76	7.96	2.82	2.31	5.39	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	934.38	26.61	5.56	4.60	5.81	4.35	2.18	4.11	3.14
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	927.85	32.17	8.76	7.53	5.09	3.87	3.26	4.68	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	1159.27	35.04	7.66	13.25	4.12	2.36	2.65	3.83	4.12
chronic myelogenous leukemia cell line:KU812	10409-106B4	2096.73	37.01	18.24	11.73	6.78	9.90	2.35	1.30	4.95
clear cell carcinoma cell line:JHOC-5	10638-108I8	295.78	33.83	4.80	8.46	5.03	4.11	4.57	3.20	2.06
clear cell carcinoma cell line:TEN	10636-108I6	691.77	21.34	7.63	7.29	4.86	10.76	1.56	1.39	3.47
colon carcinoma cell line:CACO-2	10513-107D9	897.09	19.04	9.34	4.94	2.56	4.76	2.20	0.92	4.03
colon carcinoma cell line:COLO-320	10420-106C6	2145.94	58.15	11.40	18.24	4.56	17.48	5.32	4.56	11.40
colon, adult, donor1	10082-102B1	151.13	1.19	3.57	0.00	2.38	1.19	3.57	0.00	2.38
colon, adult, pool1	10014-101C5	403.27	9.17	8.11	2.82	1.88	1.88	0.35	0.35	0.82
colon, fetal, donor1	10070-101I7	282.42	13.60	4.94	2.47	2.47	1.24	0.00	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	1237.55	0.00	50.42	0.00	0.00	13.75	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	325.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1326.22	14.45	21.25	5.52	1.70	3.40	3.40	2.55	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1339.97	24.15	15.40	9.36	2.57	4.53	3.17	2.11	5.43
cord blood derived cell line:COBL-a untreated	10449-106F8	1561.84	39.48	20.16	13.26	4.37	4.94	4.23	2.40	5.92
corpus callosum, adult, pool1	10042-101F6	729.49	22.00	19.90	6.08	2.54	2.21	1.33	1.66	2.10
cruciate ligament, donor2	10295-104G7	248.00	31.61	4.86	12.16	10.54	0.81	4.86	0.81	6.48
diaphragm, fetal, donor1	10069-101I6	232.74	10.43	1.61	0.80	4.01	3.21	3.21	0.00	3.21
diencephalon, adult	10193-103E4	340.78	28.08	9.60	12.96	4.08	4.32	2.40	2.88	3.60
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1365.27	190.58	19.52	56.71	33.29	9.18	24.11	25.26	18.14
ductal cell carcinoma cell line:KLM-1	10438-106E6	1263.48	21.54	15.39	4.10	3.59	12.82	2.82	1.28	2.56
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	766.22	33.46	6.26	9.15	5.54	2.65	5.06	4.09	4.33
ductus deferens, adult	10196-103E7	318.94	18.44	9.97	8.47	3.49	1.50	3.49	2.99	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	331.25	14.40	8.64	5.76	10.08	0.00	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	481.85	36.78	12.51	16.18	4.41	2.21	6.62	7.36	3.68
dura mater, adult, donor1	10041-101F5	682.42	21.22	21.14	5.37	3.55	14.62	1.32	2.15	2.06
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	808.57	13.10	7.55	5.33	1.11	4.66	2.00	0.67	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	1290.79	22.35	11.89	6.88	2.15	4.73	3.30	1.58	5.30
embryonic pancreas cell line:1B2C6	10604-108F1	791.73	28.98	14.18	8.63	10.48	11.10	0.00	6.78	4.93
embryonic pancreas cell line:1C3D3	10605-108F2	405.93	18.16	6.66	4.84	3.63	6.96	2.42	3.33	2.42
embryonic pancreas cell line:1C3IKEI	10606-108F3	901.55	29.95	15.44	9.26	8.34	12.97	1.23	4.32	3.09
embryonic pancreas cell line:2C6	10603-108E9	897.10	21.02	7.88	1.31	2.63	14.45	2.63	5.25	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	789.05	14.41	7.04	7.37	1.68	4.36	1.34	1.01	3.69
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	515.07	28.45	10.69	10.51	7.43	4.35	4.17	2.72	3.08
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	503.67	58.38	8.20	14.96	8.52	2.89	5.15	7.56	5.47
epidermoid carcinoma cell line:A431	10426-106D3	1204.51	28.57	12.56	7.00	4.67	13.89	1.89	1.56	3.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	970.40	33.66	8.80	8.25	3.41	7.26	3.30	2.75	3.96
epididymis, adult	10197-103E8	326.32	18.63	10.88	8.16	3.56	2.72	2.09	0.84	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	437.49	32.11	10.11	11.35	5.32	8.87	3.37	2.31	3.02
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	627.61	17.70	11.01	6.29	5.11	7.08	2.36	2.75	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1011.70	86.23	6.81	15.33	13.24	4.98	8.65	9.30	8.65
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	983.02	88.28	7.68	14.27	10.33	6.10	7.87	8.56	6.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	921.22	76.52	6.61	13.22	11.99	6.05	10.53	8.85	7.28
esophagus, adult, pool1	10015-101C6	397.11	8.71	7.01	3.19	1.17	2.87	0.85	0.42	1.17
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1419.55	28.55	21.79	5.64	4.51	14.15	2.50	3.26	3.63
eye - muscle inferior rectus, donor1	10272-104E2	268.02	12.07	4.83	16.90	12.07	7.24	9.66	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	248.30	6.31	8.42	6.31	0.00	2.10	0.00	4.21	6.31
eye - muscle medial, donor2	10299-104H2	175.61	7.44	2.98	14.88	7.44	0.00	5.95	0.00	7.44
eye - muscle superior, donor2	10297-104G9	230.45	19.49	2.29	18.34	4.59	0.00	4.59	1.15	2.29
eye - vitreous humor, donor1	10268-104D7	174.89	11.66	2.91	2.91	4.37	1.46	0.00	1.46	2.91
eye, fetal, donor1	10054-101G9	337.37	25.17	8.14	6.10	5.34	1.02	1.27	4.58	3.81
fibrosarcoma cell line:HT-1080	10758-110E2	523.28	24.75	7.31	8.85	5.13	7.44	2.82	3.59	4.23
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	702.05	38.94	9.02	14.96	5.94	4.99	7.12	5.46	4.51
frontal lobe, adult, pool1	10040-101F4	567.17	18.11	18.58	3.66	3.00	9.01	0.94	1.03	2.35
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	740.41	57.05	10.51	21.92	12.31	2.70	8.11	3.90	12.61
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	626.07	10.97	10.88	3.93	1.46	14.54	0.46	1.46	1.74
gall bladder, adult	10198-103E9	253.02	14.97	4.35	3.86	2.90	0.97	0.97	1.21	1.93
gamma delta positive T cells, donor1	11937-126A2	503.03	8.59	12.35	2.68	1.07	1.61	1.07	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	506.83	5.23	13.45	2.61	2.24	2.24	0.37	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	420.74	52.38	8.66	10.35	9.72	2.75	5.70	4.44	5.07
gastric adenocarcinoma cell line:MKN45	10612-108F9	669.61	36.17	11.41	10.25	9.28	6.19	5.42	4.26	5.42
gastric cancer cell line:AZ521	10549-107H9	1213.27	21.64	14.26	7.54	5.08	12.13	1.97	2.30	1.97
gastric cancer cell line:GSS	10560-108A2	730.35	16.47	5.49	9.15	8.24	4.58	1.83	3.66	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	725.58	69.45	9.14	23.07	18.05	4.80	8.22	10.05	4.80
giant cell carcinoma cell line:LU65	10487-107B1	679.95	26.28	7.23	6.65	3.21	2.75	2.52	2.75	3.21
giant cell carcinoma cell line:Lu99B	10433-106E1	1072.37	27.99	9.94	8.82	4.76	7.98	2.38	2.80	4.90
glassy cell carcinoma cell line:HOKUG	10688-109F4	622.05	31.18	6.24	10.48	6.98	3.74	2.00	2.74	2.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	726.94	19.21	14.46	8.55	3.06	13.62	2.01	2.43	2.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	702.61	29.07	15.45	8.71	5.48	13.20	2.67	2.11	4.35
glioblastoma cell line:T98G	10485-107A8	780.89	28.03	11.48	9.05	3.64	7.28	2.87	2.76	4.64
glioma cell line:GI-1	10413-106B8	596.01	15.82	11.13	5.56	2.93	4.10	1.46	0.59	2.93
globus pallidus - adult, donor10196	10175-103C4	382.68	5.83	6.56	2.92	1.46	3.64	2.19	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	854.09	65.42	12.20	16.35	13.67	3.17	4.88	6.10	4.88
globus pallidus, adult, donor10258	10367-105F7	235.50	17.80	6.85	5.48	4.11	5.48	1.37	4.11	2.74
globus pallidus, newborn, donor10223	10364-105F4	249.94	3.20	4.80	0.53	0.00	1.60	0.00	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	1463.39	7.34	41.60	7.34	2.45	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	338.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	188.16	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	295.68	16.96	5.44	5.12	3.84	2.56	1.28	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	780.49	8.26	9.18	12.40	5.97	6.89	1.84	6.89	2.30
hIPS +CCl2, biol_rep2	14384-156C1	777.80	6.86	11.43	17.38	3.20	7.32	2.29	5.49	1.37
hIPS +CCl2, biol_rep3	14385-156C2	658.91	1.29	6.44	10.31	5.15	4.51	1.93	2.58	0.64
hIPS, biol_rep1	14380-156B6	1011.85	1.44	10.06	8.62	2.87	7.19	0.00	1.44	1.44
hIPS, biol_rep2	14381-156B7	541.84	1.37	7.54	11.66	5.49	2.74	1.37	2.74	0.00
hIPS, biol_rep3	14382-156B8	304.56	1.10	9.93	11.03	8.83	5.52	2.21	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	816.34	70.40	10.63	24.71	8.33	3.16	8.91	9.19	7.47
heart - mitral valve, adult	10205-103F7	331.56	15.25	6.88	3.89	4.48	2.99	2.39	2.39	2.39
heart - pulmonic valve, adult	10206-103F8	518.77	27.72	11.24	7.58	8.11	0.78	5.23	3.14	1.83
heart - tricuspid valve, adult	10207-103F9	616.99	24.15	3.33	10.82	9.16	10.82	2.50	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	270.37	21.43	6.73	7.96	6.94	0.82	2.04	4.08	2.86
heart, adult, diseased, donor1	10051-101G6	201.42	11.92	5.11	3.41	3.41	0.00	2.13	2.13	0.85
heart, adult, pool1	10016-101C7	267.23	2.30	6.44	1.38	0.92	1.61	0.92	0.46	0.69
heart, fetal, pool1	10046-101G1	718.25	17.97	13.04	5.13	3.80	1.64	1.13	1.54	2.05
hepatic mesenchymal tumor cell line:LI90	10778-110G4	236.33	5.86	5.55	2.47	0.62	2.47	0.31	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	2314.14	64.22	11.89	24.97	26.16	14.27	2.38	10.70	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	2221.08	168.40	22.98	27.96	28.07	17.02	16.91	16.68	13.59
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	2475.18	209.01	22.70	32.89	30.83	20.27	16.02	25.00	17.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	2732.28	226.66	29.61	36.58	33.35	20.92	19.30	26.88	16.27
hepatoma cell line:Li-7	10484-107A7	613.80	21.69	6.67	6.56	4.00	1.67	2.45	1.78	1.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1310.32	67.34	13.47	23.42	14.27	11.66	9.75	7.74	8.34
hippocampus - adult, donor10196	10169-103B7	375.69	17.98	10.41	16.09	4.73	9.46	0.95	0.95	6.62
hippocampus, adult, donor10252	10153-102I9	488.41	49.80	9.59	12.25	7.55	5.10	5.10	7.14	3.47
hippocampus, adult, donor10258	10374-105G5	271.88	2.49	12.95	12.95	4.98	6.97	1.00	0.50	1.00
hippocampus, newborn, donor10223	10363-105F3	169.54	6.70	4.23	1.76	0.70	4.58	1.06	1.41	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1618.02	92.16	11.60	19.53	14.65	6.10	11.60	10.99	11.60
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	989.43	73.83	7.66	16.69	12.37	4.71	8.64	6.09	5.30
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	971.15	56.62	5.59	11.17	8.12	2.79	6.60	5.33	5.59
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	342.83	13.53	3.95	2.26	2.26	1.13	1.13	1.69	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	500.16	34.60	5.94	6.46	5.68	1.29	4.65	6.71	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	451.36	18.22	7.59	3.80	4.18	0.38	0.76	3.04	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	457.49	17.23	7.59	4.67	2.04	1.46	0.88	2.63	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	455.20	25.42	6.68	6.46	4.74	1.51	2.80	2.80	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	398.72	9.18	4.59	0.83	0.83	2.09	1.25	0.83	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	671.54	10.18	9.23	2.84	1.42	2.37	2.37	1.42	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	609.76	41.14	9.16	10.29	5.46	4.34	2.89	4.66	4.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	616.74	9.43	8.75	1.35	2.02	0.67	1.35	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1012.14	81.37	7.82	19.87	13.46	3.44	5.01	7.82	5.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1099.52	86.96	11.79	21.13	18.67	3.44	7.37	9.33	7.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1595.39	75.06	11.35	16.58	5.24	3.49	0.00	2.62	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	453.60	20.24	7.06	6.68	3.05	0.76	1.72	2.29	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	388.98	15.26	4.36	3.49	3.92	1.31	2.18	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	352.33	12.99	8.00	0.50	1.00	1.50	2.00	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	324.98	17.33	2.83	4.90	1.88	1.13	1.70	1.13	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	333.31	12.28	3.64	4.09	2.27	0.00	1.82	2.27	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	269.07	8.14	4.70	2.82	1.57	0.63	1.25	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	420.99	22.21	6.86	5.23	3.92	1.63	1.31	2.78	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	408.76	17.42	4.64	6.10	2.32	2.90	2.32	1.45	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	311.78	10.76	4.48	4.48	2.69	1.49	2.09	1.79	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	995.59	89.42	9.79	22.54	9.05	3.33	7.39	6.65	10.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	917.76	39.08	9.41	13.12	9.41	3.14	5.14	5.42	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1154.70	51.04	6.53	9.39	7.35	2.45	5.31	5.72	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	486.22	26.05	11.27	5.99	5.63	0.70	2.11	3.17	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	411.13	19.95	5.70	7.60	2.85	0.63	0.95	3.48	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	355.28	14.83	3.63	3.03	0.91	0.61	2.12	0.61	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	343.89	8.27	6.72	4.65	2.07	1.55	0.52	1.55	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	370.60	5.31	3.98	4.65	1.99	0.66	0.00	1.99	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	305.02	6.41	4.36	2.82	1.54	1.28	0.77	1.54	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	478.32	27.10	10.23	6.90	6.39	1.02	3.32	3.32	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	527.03	7.57	8.33	3.03	3.03	3.03	1.51	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	419.74	11.76	5.38	3.02	0.67	3.02	0.00	0.67	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1040.65	59.41	10.14	9.42	8.69	3.62	6.52	4.59	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1024.12	60.16	3.12	11.59	8.91	3.57	4.46	7.58	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	897.08	29.76	8.78	7.32	5.85	2.93	3.90	3.41	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	444.37	19.25	7.95	6.42	5.50	0.31	2.44	2.75	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4089.33	211.46	71.57	45.55	35.79	6.51	13.01	32.53	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	580.80	19.53	8.60	3.64	3.97	0.99	1.32	1.65	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	458.09	15.32	6.57	6.02	3.28	2.74	1.09	2.74	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	341.62	11.58	5.07	1.45	1.81	1.09	1.09	2.17	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	318.51	7.83	3.91	2.14	2.14	1.07	1.42	1.07	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	495.25	13.13	10.74	4.77	0.00	2.39	0.00	2.39	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	777.61	18.42	14.76	4.33	2.84	3.66	2.03	2.17	1.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	369.61	11.58	5.66	2.96	2.16	2.16	2.16	0.54	1.35
immature langerhans cells, donor1	11904-125F5	640.23	15.50	26.39	4.36	1.70	3.63	1.94	1.21	1.21
immature langerhans cells, donor2	11905-125F6	184.57	3.17	7.13	2.38	1.58	0.79	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	516.23	15.24	15.99	3.60	1.80	8.90	0.57	0.85	2.18
keratoacanthoma cell line:HKA-1	10791-110H8	364.49	12.68	4.88	4.55	2.93	3.58	0.98	2.28	0.98
kidney, adult, pool1	10017-101C8	445.27	15.62	13.02	5.31	3.30	3.20	1.40	0.90	2.10
kidney, fetal, pool1	10045-101F9	438.56	8.49	9.62	1.98	1.34	0.92	0.50	0.57	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	1216.69	9.80	27.98	5.68	1.70	28.40	1.99	1.85	2.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	362.47	14.65	8.85	3.18	4.84	3.73	2.21	1.38	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	593.81	11.93	4.40	5.14	4.04	5.50	1.47	1.65	1.65
left atrium, adult, donor1	10079-102A7	165.09	3.27	3.27	3.27	2.18	0.00	4.90	1.63	1.63
left ventricle, adult, donor1	10078-102A6	167.88	5.06	2.02	3.03	2.53	0.00	1.52	1.01	2.02
leiomyoblastoma cell line:G-402	10721-110A1	1499.38	33.11	16.14	12.31	7.93	7.66	5.47	4.65	3.56
leiomyoma cell line:10964C	10569-108B2	181.42	14.73	5.39	1.44	4.31	6.47	1.08	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	216.31	14.13	4.35	5.43	3.26	3.26	3.80	0.54	0.54
leiomyoma cell line:15425	10571-108B4	266.85	32.29	6.80	4.61	5.34	5.58	2.43	2.19	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	203.18	6.35	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	297.98	20.91	9.41	4.18	3.14	1.05	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1316.94	79.10	16.41	25.62	15.23	8.03	10.03	8.85	10.86
liposarcoma cell line:KMLS-1	10782-110G8	418.80	18.43	7.03	5.15	3.75	3.44	2.03	1.72	2.03
liposarcoma cell line:SW 872	10726-110A6	338.23	14.26	11.21	4.87	2.56	7.55	1.58	1.10	1.83
liver, adult, pool1	10018-101C9	486.35	15.56	7.78	4.21	1.78	1.13	1.46	1.94	2.11
liver, fetal, pool1	10086-102B5	122.29	0.94	0.94	0.94	1.88	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	516.66	31.06	11.23	11.96	7.15	3.21	2.62	4.67	3.94
locus coeruleus, adult, donor10252	10165-103B3	425.76	45.58	9.60	12.18	9.23	2.40	5.91	4.06	4.06
locus coeruleus, adult, donor10258	10375-105G6	240.10	7.05	4.51	3.10	1.41	2.26	1.97	2.26	1.13
locus coeruleus, newborn, donor10223	10362-105F2	549.33	20.61	6.73	6.31	3.79	7.57	1.26	0.84	1.26
lung adenocarcinoma cell line:A549	10499-107C4	758.96	9.55	10.66	2.49	2.35	8.86	0.83	0.42	1.52
lung adenocarcinoma cell line:PC-14	10408-106B3	978.27	6.89	26.89	3.45	2.76	22.06	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	560.35	17.27	14.10	4.48	4.88	15.03	1.45	2.37	1.98
lung, adult, pool1	10019-101D1	323.20	7.32	7.56	2.72	0.95	1.77	0.59	0.83	0.83
lung, fetal, donor1	10068-101I5	973.52	3.14	22.26	9.99	4.57	2.28	1.14	2.00	2.28
lung, right lower lobe, adult, donor1	10075-102A3	204.36	11.00	4.12	2.75	4.12	0.46	0.92	2.29	2.29
lymph node, adult, donor1	10077-102A5	278.81	18.93	7.10	7.10	2.84	4.26	2.37	3.79	1.89
lymphangiectasia cell line:DS-1	10727-110A7	603.83	24.11	7.67	7.67	4.82	3.73	3.73	2.63	4.38
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1753.01	55.09	12.98	18.71	8.75	11.17	4.68	4.38	11.47
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2714.14	67.96	23.79	16.99	3.40	29.73	3.40	4.25	4.25
mature adipocyte, donor1	12231-129F8	458.64	2.66	9.32	1.78	1.78	0.44	0.89	0.00	1.33
mature adipocyte, donor2	12232-129F9	442.03	6.85	8.51	2.28	1.04	1.66	1.04	0.62	1.66
mature adipocyte, donor3	12233-129G1	467.01	4.03	10.43	1.66	1.19	2.13	0.71	0.47	0.47
mature adipocyte, donor4	12234-129G2	545.91	5.53	11.32	1.84	1.58	2.11	0.26	0.00	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1658.76	32.64	36.22	5.72	4.29	26.45	1.67	3.34	2.86
medial frontal gyrus - adult, donor10196	10170-103B8	472.64	23.69	9.02	10.15	3.38	9.02	3.38	2.26	7.90
medial frontal gyrus, adult, donor10252	10150-102I6	528.73	42.67	12.32	21.15	8.46	3.49	4.78	5.52	6.07
medial frontal gyrus, adult, donor10258	10368-105F8	225.56	9.21	5.72	5.72	3.49	5.40	3.81	1.59	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	532.26	32.41	16.63	8.96	6.40	15.78	3.84	2.99	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	501.36	43.54	14.68	10.46	7.93	10.46	2.87	10.13	3.04
medial temporal gyrus, adult, donor10252	10156-103A3	552.00	50.30	14.01	25.04	10.40	4.24	4.88	4.46	6.15
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	337.10	7.71	5.78	9.63	5.78	3.85	0.00	3.85	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	7420.82	1421.01	258.37	444.96	373.19	401.90	114.83	229.66	244.01
medial temporal gyrus, newborn, donor10223	10353-105E2	194.54	8.61	6.10	2.15	0.72	3.59	0.72	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	379.00	3.89	6.49	7.79	1.30	2.60	5.19	1.95	0.00
medulla oblongata, adult, donor10252	10155-103A2	577.88	56.66	11.61	11.92	9.60	2.01	4.49	4.95	4.49
medulla oblongata, adult, pool1	10038-101F2	489.36	15.02	15.92	4.41	2.86	4.08	0.82	0.65	1.55
medulla oblongata, newborn, donor10223	10361-105F1	275.31	13.19	3.82	5.21	2.78	2.08	2.78	0.69	1.74
medulloblastoma cell line:D283 Med	10838-111E1	2621.07	183.77	25.02	57.35	36.31	9.08	17.93	26.35	23.03
medulloblastoma cell line:ONS-76	10759-110E3	711.51	29.35	4.65	7.95	5.50	5.50	3.18	2.81	3.55
melanoma cell line:COLO 679	10514-107E1	765.88	16.82	15.24	5.46	3.31	9.92	1.15	1.29	1.44
melanoma cell line:G-361	10465-106H6	785.34	56.19	16.02	20.09	9.50	7.33	6.24	4.61	6.24
meningioma cell line:HKBMM	10691-109F7	307.18	24.96	4.52	5.97	7.06	1.99	1.99	2.53	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	1258.29	79.30	34.37	15.86	15.86	6.17	7.05	11.46	7.93
merkel cell carcinoma cell line:MS-1	10844-111E7	624.21	32.92	16.33	5.96	4.15	5.18	2.07	1.56	4.93
mesenchymal precursor cell - adipose, donor1	11747-123G1	448.33	10.89	8.44	5.98	4.60	5.22	2.15	2.45	2.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	260.67	7.45	9.27	3.45	3.27	2.54	1.45	1.27	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	306.02	3.73	8.28	5.80	2.90	4.56	1.66	0.41	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	217.60	4.92	6.46	2.11	2.25	5.20	1.55	0.84	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	187.75	5.78	6.35	3.27	0.96	2.70	0.96	0.58	1.54
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	224.88	5.55	4.16	1.39	0.69	0.69	1.39	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	173.52	3.26	5.49	2.06	2.40	2.92	0.51	0.34	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	228.77	7.36	7.25	4.49	2.99	4.26	2.42	0.58	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	301.62	7.83	7.69	3.98	1.86	4.24	1.06	1.72	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	309.92	9.72	6.08	4.19	4.05	3.11	1.35	0.68	2.03
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	318.53	9.82	9.67	4.84	4.41	2.99	1.28	1.28	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	182.13	8.23	6.26	1.98	1.98	2.96	1.32	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	252.81	4.01	7.89	2.49	2.21	3.04	0.69	0.83	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	319.76	20.94	8.03	6.63	2.09	4.19	1.40	3.14	3.49
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	177.01	4.29	6.33	1.43	2.25	2.45	1.43	0.82	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	180.45	11.14	6.47	1.44	0.72	3.24	1.80	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	139.04	3.00	5.79	2.07	2.17	1.55	1.03	0.72	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	152.98	12.31	5.24	3.65	2.28	1.60	1.37	1.14	3.42
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	652.41	9.65	15.10	10.49	7.13	9.65	2.52	4.62	4.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	188.14	4.48	7.02	2.84	2.09	4.18	1.05	0.60	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	231.08	7.00	9.89	3.06	3.15	2.19	0.70	1.40	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	187.03	6.63	7.00	5.15	1.47	1.84	0.00	0.37	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	200.02	17.46	7.15	5.44	3.15	3.72	1.14	2.86	3.15
mesenchymal stem cell line:Hu5/E18	10568-108B1	466.48	48.42	6.32	8.84	6.74	3.79	5.05	5.05	7.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	178.56	7.31	3.65	3.65	0.46	2.74	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	226.37	11.25	3.07	2.05	4.09	3.33	0.26	0.77	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	201.29	8.11	3.40	1.83	1.57	2.36	0.26	0.26	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	205.80	11.09	2.46	5.24	1.23	4.01	1.54	1.23	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	235.59	13.65	5.88	3.06	3.06	4.00	0.94	0.94	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	211.20	11.51	2.37	3.05	2.71	3.38	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	200.81	10.22	5.89	4.32	3.93	1.18	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	215.01	10.19	7.41	3.71	1.85	0.93	0.46	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	338.13	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	291.59	13.84	4.61	5.19	2.31	5.48	0.58	1.15	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	209.94	5.80	4.02	2.68	1.12	3.57	1.12	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	229.30	11.54	2.88	2.16	1.92	3.12	0.72	0.96	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	330.73	22.73	1.47	0.73	2.93	8.07	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	187.30	7.38	2.01	3.02	1.34	3.02	0.34	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	209.60	11.05	4.09	4.91	2.46	4.09	0.82	0.41	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	229.38	9.45	6.44	4.30	1.72	0.86	0.00	0.43	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	161.33	8.20	5.47	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	258.25	20.66	5.16	5.16	0.00	10.33	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	215.01	6.82	2.92	4.55	2.60	3.25	0.97	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	228.43	7.27	7.27	1.45	2.91	1.45	1.45	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	199.37	3.20	4.80	2.67	1.07	2.67	0.53	1.07	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	200.35	11.45	4.91	0.82	0.00	4.91	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	183.09	8.16	2.72	1.94	3.11	1.55	0.39	0.39	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	184.69	8.39	8.39	2.10	4.20	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	207.63	5.96	0.99	1.99	0.99	2.98	0.99	2.98	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	157.32	4.77	4.77	9.53	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	207.54	6.52	5.93	1.19	1.78	2.96	0.00	1.19	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	265.62	9.75	3.66	4.87	1.22	2.44	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	216.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	219.78	8.23	5.70	4.43	1.90	3.17	0.00	1.27	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	185.21	3.79	2.41	2.41	0.69	1.72	0.69	1.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	257.90	15.04	4.30	4.30	2.15	2.15	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	183.62	3.99	0.00	3.99	7.98	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	165.31	17.22	10.33	0.00	10.33	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	166.66	12.63	4.07	2.85	6.52	0.81	1.22	2.85	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	189.08	13.51	1.59	5.56	0.79	0.00	0.00	1.59	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	172.14	12.97	2.95	4.72	2.36	0.59	1.77	1.18	5.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	173.00	10.29	2.18	1.87	1.25	1.56	0.31	1.87	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	233.92	14.70	4.01	2.67	1.34	1.34	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	279.11	14.19	2.37	5.91	0.00	0.00	2.37	1.18	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	344.11	43.66	5.14	15.41	2.57	5.14	2.57	7.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	331.12	28.91	8.95	6.88	4.82	0.69	3.44	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	238.99	18.31	3.96	4.45	5.94	0.99	0.99	1.48	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	176.08	11.22	5.61	4.49	4.49	0.00	0.00	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	208.63	23.53	3.18	7.00	3.82	0.64	1.91	1.91	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	143.46	8.46	4.43	4.03	0.81	0.40	0.40	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	146.10	13.08	2.18	0.00	0.00	0.00	0.00	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	108.97	2.53	1.27	1.27	1.27	0.00	0.00	1.27	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	120.16	8.50	4.86	6.07	0.61	0.61	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	171.72	31.63	0.00	18.08	0.00	0.00	0.00	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	162.27	18.12	0.82	4.94	5.77	0.82	4.12	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	159.53	1.59	3.97	0.40	0.79	0.79	0.40	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	142.13	4.54	2.60	0.65	0.97	0.65	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	175.20	18.34	4.07	8.15	4.07	2.04	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	560.94	4.64	7.74	1.55	0.00	10.83	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	778.65	13.47	13.47	4.25	2.83	9.45	1.18	0.71	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	774.02	19.69	7.88	6.95	2.55	4.87	0.70	1.62	3.48
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	722.24	55.56	0.00	17.09	12.82	0.00	4.27	8.55	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	418.50	13.25	2.47	8.84	1.23	4.32	2.88	2.16	2.26
mesothelioma cell line:Mero-25	10850-111F4	400.12	21.33	6.13	10.44	5.67	2.04	4.09	2.95	4.77
mesothelioma cell line:Mero-41	10851-111F5	706.04	38.87	15.40	21.02	9.53	10.02	4.16	5.13	7.33
mesothelioma cell line:Mero-48a	10852-111F6	426.03	27.01	11.07	11.07	3.99	8.41	2.21	3.10	3.99
mesothelioma cell line:Mero-82	10853-111F7	711.94	64.12	9.72	24.97	15.24	3.94	7.88	7.62	4.47
mesothelioma cell line:Mero-83	10854-111F8	514.07	42.90	5.96	13.62	9.36	4.26	6.98	5.79	4.09
mesothelioma cell line:Mero-84	10855-111F9	422.39	17.95	7.08	7.58	2.78	2.27	1.77	3.29	3.03
mesothelioma cell line:Mero-95	10856-111G1	400.01	26.71	6.21	7.87	3.73	6.00	2.28	1.66	3.93
mesothelioma cell line:NCI-H2052	10847-111F1	599.31	36.44	5.80	18.06	7.95	8.94	3.48	4.31	4.64
mesothelioma cell line:NCI-H226	10846-111E9	628.58	53.03	7.96	14.48	9.95	9.05	6.88	8.33	7.42
mesothelioma cell line:NCI-H2452	10848-111F2	360.61	20.84	9.57	10.76	4.10	5.81	1.88	2.90	4.27
mesothelioma cell line:NCI-H28	10845-111E8	637.69	49.37	12.98	17.05	9.16	9.16	6.11	5.09	4.58
mesothelioma cell line:No36	10857-111G2	463.21	28.38	6.20	13.05	4.24	5.22	3.91	3.26	1.96
mesothelioma cell line:ONE58	10858-111G3	556.54	34.68	11.92	17.34	8.40	2.71	4.34	5.96	4.88
migratory langerhans cells, donor1	11901-125F2	505.72	9.79	8.06	5.37	2.49	0.96	2.11	0.96	4.03
migratory langerhans cells, donor2	11902-125F3	264.99	3.05	3.79	1.34	0.37	0.12	0.12	0.24	0.61
migratory langerhans cells, donor3	11903-125F4	427.16	8.79	8.44	3.59	1.79	0.36	0.90	0.90	1.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	251.39	30.69	5.22	6.53	4.24	0.98	2.61	1.31	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	292.05	18.44	7.42	1.91	4.03	5.30	0.42	1.06	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	734.38	12.90	8.98	6.68	4.15	5.76	0.92	1.61	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	364.79	19.60	11.23	4.76	4.19	3.43	1.33	1.14	1.71
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1878.60	57.66	16.45	17.92	8.32	10.72	5.17	3.70	9.42
myeloma cell line:PCM6	10474-106I6	449.10	17.79	9.88	5.53	4.15	5.34	1.38	1.78	2.17
myxofibrosarcoma cell line:MFH-ino	10600-108E6	721.87	30.44	6.09	13.70	10.65	9.13	1.01	5.58	3.04
myxofibrosarcoma cell line:NMFH-1	10684-109E9	246.94	6.86	2.94	3.73	1.96	2.55	1.18	1.18	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	289.70	2.34	1.45	0.45	0.33	0.33	0.22	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	317.99	3.38	2.13	0.81	0.74	0.29	0.66	0.44	0.66
nasal epithelial cells, donor2	12227-129F4	340.58	7.73	3.31	1.66	0.00	2.76	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	2476.14	34.97	42.10	11.96	7.13	40.49	2.76	3.68	7.59
neuroblastoma cell line:NB-1	10539-107G8	1321.95	25.63	26.57	7.11	4.30	9.92	3.37	1.87	3.37
neuroblastoma cell line:NBsusSR	10607-108F4	557.80	35.64	7.80	13.08	8.86	6.54	3.59	4.22	4.64
neuroblastoma cell line:NH-12	10555-107I6	1889.23	108.83	16.03	33.73	25.72	14.54	11.74	13.42	11.74
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	811.31	92.28	11.15	21.82	17.08	8.07	14.00	10.44	8.30
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	719.68	47.36	15.05	12.35	9.50	4.59	6.02	6.02	5.23
neuroectodermal tumor cell line:TASK1	10774-110F9	856.36	39.25	10.06	11.47	6.24	3.42	6.24	3.02	6.24
neuroepithelioma cell line:SK-N-MC	10728-110A8	989.89	23.52	10.81	10.81	10.17	10.17	1.91	0.64	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	313.01	4.79	5.59	2.40	1.60	5.32	1.06	0.27	0.53
neutrophil PMN, donor1	12133-128D9	104.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	146.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1534.26	50.40	15.39	15.73	7.10	3.72	6.09	5.58	7.10
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	449.08	4.80	4.00	0.00	0.00	4.00	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	213.84	8.98	4.81	1.92	2.24	3.21	1.28	1.28	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	222.56	21.28	6.31	5.78	3.15	1.84	2.89	1.58	2.89
nucleus accumbens, adult, pool1	10037-101F1	542.09	16.69	15.84	5.16	3.00	9.09	1.41	1.50	2.16
occipital cortex - adult, donor10196	10172-103C1	696.41	16.48	22.66	8.24	2.06	6.18	8.24	0.00	8.24
occipital cortex, adult, donor10252	10163-103B1	579.40	44.28	10.73	22.01	11.81	2.95	5.37	4.29	6.71
occipital cortex, newborn, donor10223	10355-105E4	268.59	10.92	9.10	2.55	0.73	4.00	0.00	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	321.18	16.53	8.66	2.62	1.57	2.36	5.77	2.36	1.31
occipital lobe, fetal, donor1	10073-102A1	369.88	12.44	10.30	3.43	3.43	6.44	10.30	1.29	2.57
occipital pole, adult, pool1	10036-101E9	303.54	5.20	8.59	1.66	1.02	1.34	0.63	0.71	0.87
olfactory region, adult	10195-103E6	339.12	39.93	11.46	24.84	11.85	9.17	6.30	5.16	5.16
optic nerve, donor1	10277-104E7	498.26	18.01	10.01	14.01	10.01	4.00	0.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	559.40	21.30	10.94	6.95	1.94	10.71	1.71	1.71	3.87
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	839.71	11.68	7.01	5.22	1.37	5.36	1.79	0.69	2.06
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	560.97	69.76	8.13	22.35	13.38	5.42	4.91	9.99	6.26
oral squamous cell carcinoma cell line:SAS	10544-107H4	702.29	41.12	9.36	14.79	12.94	4.97	6.01	4.74	3.93
osteoclastoma cell line:Hs 706.T	10704-109H2	187.26	6.47	3.82	1.76	1.47	1.18	1.18	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	3137.50	22.42	54.19	6.54	6.54	59.80	2.80	2.80	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	552.20	13.78	6.15	4.45	1.06	2.33	2.33	1.48	1.27
ovary, adult, pool1	10020-101D2	601.42	15.46	6.90	3.49	2.71	4.28	1.14	1.22	1.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	338.59	16.32	5.87	3.48	3.48	1.83	1.47	1.10	1.28
pancreas, adult, donor1	10049-101G4	425.17	35.74	3.76	6.58	6.58	2.82	6.58	3.76	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	499.25	29.63	8.39	13.14	5.59	4.75	4.47	3.35	3.63
papillary adenocarcinoma cell line:8505C	10437-106E5	505.61	80.75	9.88	19.25	15.50	7.33	6.81	8.69	8.01
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	710.51	15.90	9.44	3.97	4.14	4.80	1.49	1.16	1.16
paracentral gyrus, adult, pool1	10035-101E8	468.23	13.55	15.56	4.30	2.01	4.67	1.65	1.01	1.01
parietal cortex, adult, donor10258	10373-105G4	313.42	10.28	11.74	11.01	3.67	3.67	0.00	4.40	0.73
parietal lobe - adult, donor10196	10171-103B9	386.54	22.57	6.58	21.63	2.82	6.58	8.46	1.88	8.46
parietal lobe, adult, donor10252	10157-103A4	497.96	44.75	13.11	26.51	9.12	3.99	3.71	4.28	5.42
parietal lobe, adult, pool1	10034-101E7	445.62	13.75	13.31	3.61	1.76	3.97	1.23	0.35	1.76
parietal lobe, fetal, donor1	10072-101I9	513.04	13.58	21.34	11.64	2.91	3.88	7.76	3.88	4.85
parietal lobe, newborn, donor10223	10356-105E5	290.12	14.21	3.36	4.11	2.62	7.10	2.24	1.12	0.37
parotid gland, adult	10199-103F1	392.20	17.88	10.48	3.08	6.17	0.62	3.08	0.62	1.85
penis, adult	10200-103F2	358.25	40.82	9.13	10.21	8.06	4.30	5.37	6.45	7.52
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	754.34	46.86	8.74	17.48	7.25	12.27	5.21	8.74	5.39
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	471.91	32.64	11.66	10.34	7.28	4.52	4.08	3.64	4.66
pineal gland - adult, donor10196	10179-103C8	405.08	8.39	8.39	11.61	2.58	2.58	1.94	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	828.51	32.57	19.54	16.58	9.48	0.00	3.55	4.74	3.55
pineal gland, adult, donor10258	10377-105G8	295.35	8.15	7.52	7.52	0.63	1.88	2.51	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	585.83	27.32	11.13	9.11	9.11	8.09	10.12	1.01	5.06
pituitary gland, adult, donor10252	10162-103A9	1106.99	39.61	26.06	12.51	7.82	4.69	2.08	7.30	4.69
pituitary gland, adult, donor10258	10378-105G9	355.82	12.77	8.51	7.66	3.40	2.55	3.40	1.70	3.40
placenta, adult, pool1	10021-101D3	423.67	11.50	9.89	4.19	2.26	2.80	1.08	1.18	1.40
plasma cell leukemia cell line:ARH-77	10840-111E3	939.70	48.60	10.06	13.64	6.75	2.91	4.24	5.96	4.90
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	495.24	12.76	7.47	2.18	3.42	1.87	1.09	0.62	2.02
pons, adult, pool1	10033-101E6	573.38	16.44	16.09	4.91	2.32	3.96	1.29	1.46	1.81
postcentral gyrus, adult, pool1	10032-101E5	359.08	11.42	10.72	2.44	1.66	4.36	0.87	0.96	1.31
promyelocytes/myelocytes PMC, donor1	12132-128D8	403.64	0.00	2.09	4.18	2.09	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	352.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	293.39	0.00	0.00	0.00	0.00	11.74	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	570.70	32.34	8.01	10.20	4.37	7.87	6.12	3.35	4.95
prostate cancer cell line:PC-3	10439-106E7	1232.94	69.88	11.98	23.78	12.34	4.72	7.44	6.17	7.99
prostate, adult, pool1	10022-101D4	440.67	5.80	8.34	2.18	2.18	1.54	0.73	0.63	1.09
putamen, adult, donor10196	10176-103C5	531.62	62.56	17.23	12.04	12.75	17.23	4.96	5.90	7.79
putamen, adult, donor10252	10152-102I8	333.32	13.73	7.84	3.92	3.92	7.84	1.96	0.00	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	642.57	3.28	10.93	10.93	5.46	13.11	1.09	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	339.47	26.09	9.66	16.19	9.91	8.70	3.62	3.62	3.87
putamen, newborn, donor10223	10365-105F5	542.75	13.49	12.74	5.25	0.75	14.24	0.75	3.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	1430.82	22.98	14.55	8.73	7.86	13.09	1.16	2.33	6.40
rectum, fetal, donor1	10067-101I4	546.66	2.78	4.17	5.56	1.39	1.39	2.78	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	251.22	4.45	4.45	2.12	0.85	2.33	0.64	0.42	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	145.80	9.11	0.83	2.49	1.24	0.41	1.24	1.24	0.83
retina, adult, pool1	10030-101E3	396.60	13.02	10.74	2.58	3.18	1.69	1.19	0.70	1.59
retinoblastoma cell line:Y79	10475-106I7	1743.53	89.89	17.93	27.80	19.74	12.21	10.91	7.01	12.73
rhabdomyosarcoma cell line:KYM-1	10787-110H4	878.34	40.33	10.57	16.23	7.38	8.73	7.01	5.41	6.15
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	3676.13	64.11	37.12	21.37	12.94	19.40	4.22	7.03	7.87
sacrococcigeal teratoma cell line:HTST	10695-109G2	335.73	9.09	9.85	5.30	0.76	0.76	0.76	2.27	1.52
salivary acinar cells, donor1	11771-123I7	535.42	43.38	12.79	8.42	9.06	5.18	5.02	4.05	3.72
salivary acinar cells, donor2	11772-123I8	420.36	39.65	9.50	10.19	7.57	4.54	3.58	5.23	3.86
salivary acinar cells, donor3	11773-123I9	424.38	11.92	15.23	7.28	9.27	4.63	1.99	1.99	0.66
salivary gland, adult, pool1	10093-102C3	229.92	1.14	6.86	3.43	1.72	0.57	0.00	0.00	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	357.56	11.21	10.62	3.88	1.43	7.93	1.10	1.26	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	309.87	10.23	8.93	4.94	2.00	7.52	1.18	1.06	2.00
seminal vesicle, adult	10201-103F3	323.26	20.10	10.58	13.23	0.00	3.70	3.70	3.70	6.88
serous adenocarcinoma cell line:JHOS-2	10639-108I9	533.95	45.67	8.75	9.23	8.50	2.67	3.89	3.89	4.13
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	304.98	9.81	9.06	3.02	1.76	0.50	1.51	0.50	2.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	527.86	20.07	13.05	11.04	2.01	2.01	6.02	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	595.71	52.92	5.64	13.30	6.72	2.55	5.64	5.91	4.16
signet ring carcinoma cell line:Kato III	10436-106E4	704.39	23.43	14.04	7.85	3.09	2.76	1.99	0.99	3.43
signet ring carcinoma cell line:NUGC-4	10483-107A6	1083.17	15.61	11.10	6.58	2.84	4.26	0.90	2.19	2.19
skeletal muscle - soleus muscle, donor1	10282-104F3	517.81	27.66	12.77	30.50	11.35	6.38	5.67	4.26	7.09
skeletal muscle, adult, pool1	10023-101D5	675.61	10.67	14.15	5.04	2.64	4.68	0.72	0.84	1.32
skeletal muscle, fetal, donor1	10066-101I3	299.49	4.02	5.03	2.01	3.02	1.01	0.00	3.02	1.01
skin, adult, donor1	10074-102A2	312.12	6.79	0.00	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	565.58	25.25	8.84	3.79	3.79	5.05	5.68	1.89	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	406.90	13.01	10.01	4.67	2.00	6.00	1.67	1.00	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1087.77	132.39	19.86	43.81	19.86	3.15	16.08	23.96	13.24
small cell lung carcinoma cell line:DMS 144	10841-111E4	654.96	24.29	12.34	6.55	5.59	5.98	2.70	1.93	3.08
small cell lung carcinoma cell line:LK-2	10541-107H1	1510.48	25.88	36.43	9.56	6.10	14.83	2.31	3.63	2.80
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2282.94	132.70	8.04	41.18	23.16	5.47	13.35	15.28	14.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	810.22	38.35	14.82	15.04	11.77	5.67	7.41	5.23	4.14
small intestine, adult, pool1	10024-101D6	470.84	13.74	10.87	4.30	2.15	1.91	1.07	1.31	1.19
small intestine, fetal, donor1	10064-101I1	465.84	43.00	6.88	9.09	8.85	2.46	5.65	5.65	6.14
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	373.39	41.03	7.18	7.69	8.21	0.51	4.62	4.62	3.08
smooth muscle, adult, pool1	10048-101G3	381.48	25.85	7.50	9.05	3.88	2.33	2.07	2.84	2.84
somatostatinoma cell line:QGP-1	10781-110G7	692.30	13.94	17.42	4.02	5.09	8.84	2.14	1.34	1.07
spinal cord - adult, donor10196	10181-103D1	505.61	26.38	10.55	9.41	4.13	5.05	4.13	5.05	0.92
spinal cord, adult, donor10252	10159-103A6	827.18	34.70	12.22	11.04	9.07	2.37	2.37	3.55	3.94
spinal cord, adult, donor10258	10369-105F9	327.91	2.77	15.91	11.07	5.53	2.77	1.38	1.38	1.38
spinal cord, fetal, donor1	10056-101H2	292.72	20.73	9.76	8.54	1.83	2.44	3.05	1.83	4.88
spinal cord, newborn, donor10223	10359-105E8	544.63	28.47	6.43	10.56	6.43	4.13	4.13	5.05	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	344.56	9.86	8.81	2.24	2.54	3.73	0.75	0.30	1.19
spleen, adult, pool1	10025-101D7	506.07	9.69	10.13	3.19	2.53	5.29	0.88	1.32	1.10
spleen, fetal, pool1	10044-101F8	415.95	6.52	7.55	1.99	0.95	1.67	0.56	0.48	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	939.48	45.96	11.90	13.04	7.76	4.66	5.59	4.14	6.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	781.72	28.86	10.63	6.84	5.13	7.97	3.04	1.52	3.04
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	478.05	64.30	12.58	13.63	11.18	3.49	8.74	8.74	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	376.08	24.63	2.35	5.08	4.30	2.74	0.78	1.95	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1332.02	48.18	33.43	18.57	7.43	25.66	6.19	3.60	8.55
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	628.20	22.03	5.93	6.78	4.66	2.54	0.85	1.69	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	626.14	11.85	7.19	7.19	0.85	5.50	1.27	2.12	3.38
stomach, fetal, donor1	10062-101H8	605.54	18.16	9.61	1.07	3.20	5.34	2.14	1.07	7.48
submaxillary gland, adult	10202-103F4	302.50	22.22	6.27	6.84	2.85	0.57	3.42	2.85	2.28
substantia nigra - adult, donor10196	10178-103C7	6241.53	1248.31	271.37	1031.21	434.19	54.27	54.27	217.10	271.37
substantia nigra, adult, donor10252	10158-103A5	557.28	52.76	8.10	13.50	8.93	1.25	6.85	4.78	7.48
substantia nigra, adult, donor10258	10371-105G2	241.56	0.00	12.93	9.83	5.17	3.62	0.00	3.10	0.00
substantia nigra, newborn, donor10223	10358-105E7	262.85	9.89	2.12	2.12	1.41	2.83	0.71	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	1061.27	72.22	8.48	18.34	13.53	11.92	5.96	5.50	5.50
temporal lobe, adult, pool1	10031-101E4	281.10	7.97	8.82	2.46	0.76	2.97	0.85	0.85	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	346.87	17.09	6.41	5.70	2.14	4.99	4.27	2.85	7.12
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	375.81	22.86	9.23	10.11	3.52	9.67	3.52	2.20	3.96
tenocyte, donor1	11763-123H8	301.97	30.72	4.54	10.12	5.93	8.03	0.70	2.79	2.79
tenocyte, donor2	11765-123I1	175.49	18.31	4.20	2.67	2.29	1.53	0.76	2.29	1.91
tenocyte, donor3	11768-123I4	251.31	23.35	5.56	6.67	4.45	6.67	2.22	2.97	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1803.79	115.57	28.55	35.86	22.09	4.42	16.15	10.71	13.60
teratocarcinoma cell line:NCR-G1	10798-110I6	589.15	31.91	6.63	10.17	4.93	2.16	4.16	3.55	4.16
teratocarcinoma cell line:PA-1	10807-111A6	858.11	43.86	4.34	19.22	6.66	1.70	8.06	4.18	8.06
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	819.06	39.61	12.69	13.58	7.36	4.57	6.86	3.05	6.60
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1206.75	47.65	11.72	18.91	9.45	6.43	4.92	2.65	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	1169.69	24.32	9.60	14.18	13.20	3.27	4.80	5.56	4.36
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	911.32	111.39	14.01	28.66	19.87	11.07	11.07	19.54	6.84
testis, adult, pool1	10026-101D8	371.94	11.60	13.64	2.15	2.79	5.48	1.50	1.29	1.29
testis, adult, pool2	10096-102C6	308.99	40.15	18.04	19.40	7.67	11.73	6.32	6.32	8.57
thalamus - adult, donor10196	10168-103B6	442.70	13.25	15.46	8.83	5.52	0.00	6.62	2.21	4.42
thalamus, adult, donor10252	10154-103A1	669.52	62.36	11.10	15.78	9.22	3.75	7.19	5.31	5.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	483.44	0.00	1.54	6.16	1.54	4.62	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	172.10	5.60	3.62	3.46	1.32	1.81	0.82	0.99	0.49
thalamus, newborn, donor10223	10366-105F6	248.54	7.48	6.90	3.45	2.30	5.18	2.30	2.30	1.73
throat, adult	10209-103G2	375.25	27.71	9.24	4.74	0.75	1.00	2.50	1.00	5.24
throat, fetal, donor1	10061-101H7	352.24	21.94	8.84	11.27	5.79	0.91	2.44	1.83	3.66
thymic carcinoma cell line:Ty-82	10803-111A2	1140.72	29.81	9.34	13.51	3.58	7.75	5.76	3.78	5.96
thymus, adult, pool1	10027-101D9	848.80	22.57	11.73	5.57	3.88	1.69	1.99	2.39	2.39
thymus, fetal, pool1	10043-101F7	789.26	17.14	9.25	4.47	2.91	2.18	1.45	1.77	2.08
thyroid carcinoma cell line:KHM-5M	10776-110G2	488.50	18.48	8.78	6.38	1.86	4.52	3.72	1.60	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	494.09	30.59	7.82	9.22	5.03	6.15	3.07	3.35	4.89
thyroid, adult, pool1	10028-101E1	511.73	9.52	9.33	3.83	2.52	1.12	1.21	0.56	1.12
thyroid, fetal, donor1	10060-101H6	281.86	20.30	7.12	6.33	5.54	1.05	2.11	2.37	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	354.16	9.24	6.16	21.56	6.16	3.08	3.08	3.08	12.32
tongue, adult	10203-103F5	476.09	40.47	11.63	12.09	6.98	2.56	3.95	5.35	2.79
tongue, fetal, donor1	10059-101H5	372.02	24.43	7.09	5.52	3.94	2.76	3.94	1.58	1.58
tonsil, adult, pool1	10047-101G2	623.09	8.72	13.52	2.10	1.70	3.41	1.20	0.50	1.50
trachea, adult, pool1	10029-101E2	544.21	11.04	8.59	2.94	2.70	6.38	0.74	1.15	1.55
trachea, fetal, donor1	10058-101H4	389.70	19.23	5.39	3.08	6.16	3.46	1.92	2.69	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	376.24	20.55	6.02	9.92	4.96	2.83	4.25	3.19	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	1054.60	15.30	11.55	4.66	2.94	7.40	0.71	0.81	1.72
transitional-cell carcinoma cell line:JMSU1	10492-107B6	1464.55	75.52	28.05	22.88	10.65	27.11	8.93	8.93	10.81
tridermal teratoma cell line:HGRT	10694-109G1	530.81	5.71	9.51	5.71	3.81	13.32	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	350.96	23.87	8.72	6.69	4.74	5.16	3.22	1.78	2.96
umbilical cord, fetal, donor1	10057-101H3	302.54	25.04	2.09	0.00	4.17	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	438.00	3.75	9.04	2.73	2.90	2.56	0.34	0.34	1.02
uterus, fetal, donor1	10055-101H1	442.31	21.50	4.61	9.73	5.63	2.56	3.07	3.58	1.54
vagina, adult	10204-103F6	316.64	9.05	2.58	2.58	1.94	0.65	0.00	0.65	0.00
vein, adult	10191-103E2	313.45	14.69	9.43	3.29	3.73	1.75	1.32	2.63	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	420.32	25.90	8.28	10.68	5.07	3.74	1.60	4.01	2.94